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3. Discussion 








Chemicals and strains.  
Buffers, salts, and reagents, including the assay components ATP, NMN, NaMN, NAD, 
NaAD, ADP-ribose, inorganic pyrophosphatase and alcohol dehydrogenase were purchased 
from standard commercial sources. Enzymes for PCR and DNA manipulations were from 
New England Biolabs Inc. (Beverly, MA). Plasmid purification kits were from Promega 
(Madison, WI). PCR purification kits were from Roche Diagnostics (Indianapolis, IN). 
Nickel-nitrilotriacetic acid resin was from Qiagen Inc. (Valencia, CA). Oligonucleotides for 
PCR and sequencing were synthesized by Sigma-Genosys (Woodlands, TX). E. coli strains 
DH5α (Invitrogen) and BL21/DE3 (Stratagene, La Jolla, CA) were used for gene cloning and 
protein overexpression, respectively.  
 
Gene cloning, protein overexpression and purification 
Generation of F. tularensis and B. anthracis expression constructs. The genes for ftNadE* 
and ftNadM (locus tags FTL_0685 and FTL_0452, respectively) were amplified by PCR from 
F. tularensis subsp. Holarctica LVS genomic DNA. The genes for baNadD and baNadE 
(BA_1998 and BA_4558, respectively) were PCR-amplified from B. anthracis strain Ames 
genomic DNA (gifted by Dr. R. Liddington). The following primers were used:  
ftNadE*, 5′-GGTCAGATCATGAAAATAGTTAAAGA-3' (forward) and  
5′-ACTTATGTCGACTCAGAAATTAGG-3′ (reverse); 
 ftNadM, 5′-cggaggACATGTATGATATTTCAGTTT-3′ (forward) and  
5′- cTATCACCCTGCAGTTATAGTTTTTTACC -3′ (reverse);  
baNadD, 5′-GCACTCATGAGAAAAATTGGCATCATTG -3′ (forward) and  
5′-GAAGTCTGCAGTCACGATTCATACAACC-3′ (reverse); and  
baNadE, 5′-GGACACATCATGACATTACAAGAACAGAT-3′ (forward) and 
 5′-TTTATGGTCGACTTATTTCCACCAATC-3′ (reverse).  
The gel-purified PCR products were inserted into a pET-derived vector (1) containing the T7 
promoter, His6-tag, and TEV-protease cleavage site and were sequenced to confirm PCR 
accuracy.  
 
Production and purification of ftNadE*,ftNadM, baNadD, and baNadE. All recombinant 
proteins were expressed as N-terminal fusions with a His6-tag and a TEV-protease cleavage 
site in E. coli strain BL21/DE3. Cells were grown to an optical density at 600 nm of 0.8–1.0 at 
37°C of LB medium. IPTG was added to 0.8 mM, and harvesting was performed after 12 h of 
shaking at 20°C. Proteins were purified from 6-liter cultures by chromatography on a Ni-NTA 
agarose column followed by gel filtration on a HiLoad Superdex 200 16/60 column 
(Pharmacia) with an AKTA FPLC system. The full protocol was similar to a procedure 
previously described (2). Proteins were purified to homogeneity as assessed by SDS-PAGE. 
Purified recombinant NadE enzymes from Corynebacterium glutamicum and Helicobacter 
pylori were obtained using the same techniques (unpublished results). 
 
Structural analysis of ftNadE* 
For crystallization of ftNadE*, the 6xHis-tag was removed by treatment with TEV protease 
and the tag-removed protein was further purified with an ion exchange column Resource Q 
(GE Healthcare Life Sciences). The cocrystals of ftNadE* complexed with AMP, 
pyrophosphate (PPi), and Mg2+ were grown in a sitting-drop vapor diffusion setting at 20°C 
with 8 mg/ml protein mixed with an equal volume of reservoir solution containing 0.2M K/Na 
tartrate and 16% PEG 3350 in the presence of 5 mM ATP, 10 mM MgCl2, and 20 mM 
NaMN. For data collection, ftNadE* crystals were transferred stepwise to a cryoprotection 
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solution containing the original reservoir solution and PEG 3350 increased to a final 
concentration of 40%. The diffraction data were collected on an R-AXIS IV image plate 
detector with X-ray generated by Rigaku FR-E SuperBright generator equipped with Osmic’s 
VariMac focusing device and were processed with HKL2000 (3). The structure was solved by 
the molecular-replacement method of Molrep (4) using the Bacillus subtilis (bsNadE) 
structure (5) as the initial search model (pdb code 1kqp). The refinement and manual model 
building were performed with the program Refmac (6) of the CCP4 program suite(7) and 
COOT (8). The crystal data and current refinement statistics of ftNadE* structures are listed in 
SI Table 4. 
 
Enzyme assays and steady-state kinetic analyses. 
These assays were used to assess apparent values of kinetic parameters toward pyridine 
nucleotide substrates (NaMN, NMN, and NaAD at 10 μM–8 mM)) at constant saturating 
concentration of other substrates (2 mM ATP for all enzymes and 4 mM NH4Cl for NadE 
enzymes). The amount of enzyme in the reaction mixture was maintained at a level between 
0.1 and 500 μg/ml, leading to 1–10% substrate consumption within the incubation time. For 
HPLC assays, the linearity of response was assessed by the analysis of aliquots taken at 2–3 
time points over the course of reaction. Apparent values of Km and kcat were calculated by 
fitting initial rates to a standard Michaelis–Menten model using the software Prism 4 
(GraphPad), unless otherwise stated.  
 
Continuous coupled assays - NaMN and NMN adenylyltransferase activity 
The respective activities of NadD and NadM enzymes were measured with continuous assay 
coupling NAD formation to the alcohol dehydrogenase-catalyzed conversion of NAD to 
NADH as described (9) with slight modifications. Reactions were performed in a reduced 
volume of 100 uL using UV-transparent micro-cuvettes (BrandTech Scientific, Essex, CT) at 
37 °C and monitored by the change in UV absorbance at 340 nm using a Beckman DU-800 
spectrophotometer. Assay mixtures contained 2 mM ATP, 10 mM MgCl2, 20 mM 
semicarbazide, 6 U/ml alcohol dehydrogenase, and 60 mM ethanol in 50 mM Hepes (pH 7.5). 
The reaction was started by adding either NMN or NaMN to 1 mM. To evaluate the NaMN-
specific activity, an excess of pure recombinant NAD synthetase from C. glutamicum and 
NH4Cl to 5 mM were also added. An NADH extinction coefficient of 6.22 mM – 1 cm – 1 was 
used for initial rate calculations using Multimode Detection software (Beckman).   
 
Continuous coupled assay - NAD synthetase activity 
The measurement of NAD synthetase (NADS) activity was determined as reported 
previously(10). Briefly, the reactions containing 2 mM ATP, 10 mM MgCl2, 20 mM 
semicarbazide, 6 U/ml alcohol dehydrogenase, 60 mM ethanol, 5 mM NH4Cl in 50 mM 
Hepes (pH 7.5) were initiated by adding NaAD to 1 mM.  
 
Discontinuous (2-step) coupled assay - NMN synthetase activity 
We developed a two-step spectrophotometric assay coupling the NMN synthetase activity to 
NADH formation via conversion of NMN to NAD by added excess of the purified 
recombinant ftNadM, followed by alcohol dehydrogenase-catalyzed conversion of NAD to 
NADH. The first step reaction (in 200 uL: 100 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM 
NaMN, 2 mM ATP, 5mM NH4Cl) was started by the addition of NadE enzyme. After 
incubation at 37oC, the reaction was stopped by rapid cooling and removing of the active 
enzyme by microultrafiltration with Microcon YM-10 centrifugal filters (Amicon, Bedford, 
Mass.). A complete conversion of NMN into NADH was then accomplished by addition of 
one volume of the coupling buffer: 50 mM Hepes (pH 7.4), 20 mM Semicarbazide, 120 mM 
EtOH, 1.4 U of alcohol dehydrogenase and pure recombinant ftNadM. The mixture was 
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incubated at 25 °C for 20 min and NADH concentration was determined by absorbance at 340 
nm (molar extinction of NADH used for all calculations was 6,220 M-1 cm-1).  
HPLC-based assay – NMN and NAD synthetase activities, and in vitro pathway 
reconstitution 
A direct HPLC-based assay was used to directly assess and compare NMN synthetase and 
NAD synthetase activities of all NadE enzymes (including those from C. glutamicum and H. 
pylori), to determine steady-state kinetic parameters (for NaMN and NaAD) of ftNadE* and 
baNadE enzymes and to monitor pathway reconstitution using mixtures of purified 
recombinant enzymes. Kinetic assays were carried out in 0.1 ml reaction mixtures in 96-well 
plates containing 50 mM Hepes (pH 7.5) with 10 mM MgCl2 and 4 mM NH4Cl. The enzymes 
ftNadE* and baNadE were incubated with 2 mM ATP and varying concentrations (from 50 
microM to 12.5 mM NaMN or NaAD at 37°C.  For in vitro pathway reconstitution, mixtures 
of purified ftNadE* and ftNadM or baNadD and baNadE (3-100 μg ml−1 each) were incubated 
with 2 mM ATP, 1 mM NaMN, 10 mM MgCl2 and 4 U/ml inorganic pyrophosphatase in 50 
mM Hepes, pH 7.5 at 37 °C for 0.5-1 h and analyzed by ion-pair HPLC on LC-18T column 
(Supelco). Reactions were stopped by adding half-volume of ice-cold 1.2M perchloric acid 
(HClO4). After 10 min at 4 °C, samples were centrifuged and brought to pH 6 by 0.8M K2CO3 
addition. Proteins were removed from the supernatant by microultrafiltration and the filtrates 
were analyzed by RP-HPLC using a Shimadzu Prominence HPLC system with LC-10AD 
solvent delivery system, CBM-20AD system controller, SPD-20AD UV/Vis detector, SIL-
20A auto sampler, CTO-20A column oven and DGU-20A3 on-line degasser. The separation 
was performed at room temperature on a Supelco LC-18-T (15 cm × 4.6 mm, 3 μm particle 
size) column equipped with Supelguard LC-18-T (2.0 cm × 4.0 mm, 5 μm particle size) guard 
column (Supelco, Bellefonte, PA), monitoring absorbance at 254 nm.  Data were collected 
and processed by EZstart software package (Version 7.3). Chromatographic conditions and a 
standard separation are illustrated in Supplementary Fig.4. Molar areas were determined using 
calibration with standard solutions under the same chromatographic conditions.  
 
NMN synthetase activity in cleared cellular lysates. Crude extracts of F. tularensis strain 
U112 wild-type and NadE* knockout mutant were prepared from mid log-phase grown cells 
as described above for protein purification. Briefly, cells were harvested, and resuspended for 
20 min in a buffer with 1 mg/ml lisozyme, 2 mM PMSF, and 2 mM β-merchaptoethanol. 
After a cycle of thawing and sonication, cell debris was removed by centrifugation and the 



















Mathematical Modelling of the Mixed Enzymatic Solution System 
Mathematical model 
A mathematical model describing a well-mixed enzymatic solution system, depicted in 
Scheme 1, is a set of standard kinetic mass balances [1] 
                                                           ,][ 310 VVVdt
Ad
−−=             (1) 
                                                           ,][ 21 VVdt
Bd
−=                          (2) 
                                                           ,][ 43 VVdt
Cd
−=                     (3) 
                                                           ].[][ 42 DkVVdt
Dd
D ⋅−+=  (4) 
Here t is time, [A] is the concentration of NaMN, [B] is the concentration of NMN, [C] is the 
concentration of NaAD, and [D] is the concentration of NAD (the nomenclature of metabolite 
and enzyme names is provided in the main text and in Figure 1). V0 is the constant influx of 
NaMN into the system and kD is the degradation/utilization kinetics rate constant for NAD. 
The reaction rates V1, V2, V3, and V4, and the corresponding kinetic constants are provided in 
SI Table 5 and SI Table 6, respectively. The mathematical expressions for the kinetic rates 
(i.e. V1, V2, V3, and V4) are obtained using a standard Michaelis-Menten approach (11, 12).  
Below the following two different modelling situations are considered in detail, 
(1) simulation of transient time courses in a closed well-mixed “test-tube” enzymatic solution 
system (i.e. when V0 = kD = 0) and (2) the analysis of the steady-state fluxes and the 
metabolite concentrations in an open “cellular subsystem” with a non-zero mass flow across 
the subsystem’s systematic boundary. In this case, the nonzero values of V0 and kD are set so 
that [D] = 1 (mM) at the steady-state. 
To relate the data in Table 1 and 2 here (i.e. ki, Ki, i = 1, 2, 3, 4) to the corresponding kinetic 
parameters in Table 1 of the main text, we note that (k1, K1) = (kcat, Km) for ftNadE* (NaMN) 
and baNadE (NaMN), respectively; (k2, K2) = (kcat, Km) for ftNadM (NaMN) and baNadD 
(NMN), respectively;  (k3, K3) = (kcat, Km) for ftNadM (NMN) and baNadD (NaMN), 
respectively; and (k4, K4) = (kcat, Km) for ftNadE* (NaAD) and baNadE (NaAD). 
 
Transient time courses in the closed “test-tube” enzymatic system 
In this case, the zero values of the parameters V 0 and kD are used, V0 = kD = 0. At time t = 0, 
initial conditions [A0] = 1 (mM) and [B0] = [C0] = [D0] = 0 (mM) were always used. By 
summing up the equations (1) through (4) with zero V0 and kD, it can be shown that the total 
sum of metabolite concentrations is preserved and does not change in time t, 
  ].[][][][][ 0ADCBA =+++   (5) 
Conservation relationship (5) is called a total moiety conserved pool. Mathematically, (5) 
means that differential equations (1) – (4) are linearly dependent and, therefore, to calculate 
the corresponding time courses in (1) – (4), only three differential equations, combined with 
the algebraic equation (5), are required. Specifically, equations (2) – (4) were integrated to 
calculate transient concentration profiles [B], [C], and [D], while concentration profile [A] of 
metabolite A was obtained from (5) using equations (6) – (9), 
  ],[][][][][ 0 DCBAA −−−=  (6) 
  ,][ 21 VVdt
Bd
−=  (7) 
  ,][ 43 VVdt
Cd
−=  (8) 
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  .][ 42 VVdt
Dd
+=  (9) 
The dependence of V1, …, V4 on [A] is excluded from (7) – (9) using (6) substituted into the 
corresponding mathematical expressions for rates V1 , …, V4 given in Table 1. 
To estimate the contribution of the two different routes, Route II utilizing enzymes 
ftNadE and ftNadM and Route I utilizing enzymes baNadD and baNadE, into the formation 
of the final product D (i.e. NAD), equation (9) was additionally replaced by two equations 
                                                                     ,][ 21 Vdt
Dd
=  (10) 
                                                                     .][ 42 Vdt
Dd
=  (11) 
Here [D] = [D1] + [D2],  D1 can be interpreted as a “fraction” of metabolite D formed through 
flux V2 (i.e. DBA EE ⎯→⎯⎯→⎯ 21 ) and D2 is a “fraction” of D formed through V4 (i.e. 
DCA EE ⎯→⎯⎯→⎯ 12 ).  Equations (6) – (8), (10) and (11) were integrated using the Matlab© 
procedure ode15s with relative and absolute tolerances RelTal = AbsTol = 10-7, respectively. 
All integration calculations were automatically terminated when the concentration [D] of 
metabolite D reached ~90-99% of the initial concentration [A0] of metabolite A using a simple 
event procedure available through the Matlab© interface. The corresponding time courses are 
depicted in SI Figures 10 and 11.  To relate SI Figure 10 and 11 to Fig. 3 (a, b) in the main 
text, we note that Figure 2(a) here corresponds to Fig. 11(a) in the main text, while Figure 
11(c) here corresponds to Fig. 3(b) of the main text, respectively. We also note that vanishing 
concentrations of the intermediates do not assume that the corresponding fluxes leading to and 
from a vanishing intermediate are also vanishing. Specifically, although the concentration of 
intermediate B depicted in SI Figure 10(c) and (e) is negligible small compared to the other 
concentrations, the flux through B (i.e. fraction D1) is not small meaning that intermediate B 
is not accumulated in the mixture and it is instead converted to final product D rapidly. 
From SI Figure 10, we find that in the case of organism F 100% of NAD is produced 
utilizing Route II when the concentration of E1 is greater than the concentration of E2,  that is 
[E1]:[ E2] = 10:1 (see SI Figure 10 (a) and (b)). In the other two cases, depicted in SI Figure 
10 (c) – (f), both enzymatic routes are involved in the formation of NAD. However, such 
scenarios may be unlikely to happen in or could be highly inefficient for organism F as in this 
case it can take 15-150 times longer to produce NAD. Note that for organism B, Route I 
always prevails over Route II in the formation of NAD as seen from SI Figure 11. 
 
The analysis of steady states in the open enzymatic system 
To evaluate steady-state fluxes in the open enzymatic system, the non-zero values of 
parameters V0 and kD were set. Specifically, we used V0 = 10-3 (mM·s-1) and kD = 10-3 (s-1). 
After summing up equations (1) through (4) with non-zero values of V0 and kD, we obtain  
      ].[][ 0 DkVdt
Dd
D ⋅−=   (12) 
It follows from (12), that the steady state concentration [D] of metabolite D is uniquely 
defined by the values of V0 and kD and [D] is independent of the other kinetic parameters, 
                                                               .][ 0
Dk
V
D =                  (13) 
Due to the choice of the specific values for V0 and kD, we have [D] = 1 (mM). 
The steady-state values of metabolite concentrations and fluxes for organisms F and B with 
different ratios of enzyme concentrations E1 and E2 were obtained using a Matlab© numerical 
solver fsolve utilizing the Gauss-Newton method applied to the system of algebraic equations 
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                                 ,0310 =−− VVV             (14) 
                                                                ,021 =−VV                     (15) 
                                                                ,043 =−VV                                                      (16) 
                        .0][42 =⋅−+ DkVV D  (17) 
The equations (14) – (17) are obtained from the differential equations (1) – (4) by equating the 
time derivatives to zero values,  d[A]/dt = d[B]/dt = d[C]/dt = d[D]/dt = 0 (mM·s-1). 
Appropriate approximations for the solutions to (14) – (17), used as initial conditions for the 
Newton-like solver fsolve, were generated by the direct integration of equations (1) – (4)  over 
a long time interval, tend = 104 (s). The stability of the corresponding steady-state solutions 
was calculated using Matlab© function eig utilized to calculate the eigenvalues of the Jacoby 
matrix of partial derivations of the linearization of (14) – (17) at the solution. The Jacoby 
matrix was directly available from fsolve function. The corresponding steady state 
concentrations and fluxes are summarized in Table 3 for different values of enzyme 
concentrations ratios in organisms F and B. An example of eigenvalues (i.e. λk, k = 1, … , 4) 
calculated to evaluate the stability is given below for organism F with [E1]:[E2] = 10:1. The 
negative real parts of the eigenvalues are indicative of the asymptotical stability of the 
algebraic solutions to (14) – (17) viewed as the corresponding steady states in the full system 
(1) – (4), 
λ1 = -1.00·10-3, 
λ2 = -2.51·10-3, 
λ3 = -3.05·10-4,  
λ4 = -8.58·10-5. 
From the comparison of the steady-state fluxes, we find that for organism F, Route II, 
DBA EE ⎯→⎯⎯→⎯ 21 , is exclusively utilized in the formation of NAD when [E1]:[E2] = 10:1 
and both routes 1 and 2 are active when [E1]:[E2] = 1:1. We could not calculate any 
reasonable distributions of steady-state metabolite concentrations and fluxes in the case of 
[E1]:[E2] = 1:10 which may be indicative of the biological infeasibility of this case for 
organism F. The modelling data for organism B, provided in Table 3, show that in all the three 
cases, NAD is solely produced utilizing Route I only. 
 
Francisella tularensis nadE* knockout mutant and complementation study 
To address the in vivo function of ftNadE* we used a nadE transposon mutant of F. tularensis 
subsp. novicida strain U112. The transposon T20 in the mutant tnfn1_pw060328p05q173 is 
inserted in the nadE gene (FTN_1278) between nucleotide (nt) 414 and nt 415. The insertion 
was confirmed by PCR and sequencing using the transposon-specific primer KAN-125 and 
the flanking primer NADE-ECO. The same approach was used to analyze the viable nadM 
transposon mutant. The transposon T20 in the mutant tnfn1_pw060328p06q193 is inserted in 
the nadM gene (FTN_0483) between nt 565 and nt 566. The insertion was confirmed by PCR 
and sequencing using the transposon-specific primer KAN-125 and the flanking primer 
NADM-SAL. The mutants tnfn1_pw060328p05q173 and tnfn1_pw060328p06q193 were 
obtained from a comprehensive sequenced-defined transposon mutant library(13). The PCR 
reactions were performed with these primers:  
KAN-125, 5’-AACGCAGACCGTTCCGTGGC-3’,  
NADE-Eco, 5’-ATGAATTCTGGGCAAAGAATTGCTGAAATAACTAAGG-3’, and  
NADM-Sal, 5’-ATGTCGACGGGTCATTAAAGCTTGTATTTAGGGAGC-3’.  For 
complementation study the nadE gene was PCR-amplified from F. tularensis subsp. novicida 
genomic DNA with primers  
NADE-NcoI (CGCGCGCCATGGGCATGAAAATAGTTAAAGATTTTAGTCCTAAAGA) 
and NADE-EcoRI (CGGAATTCTCAGAAATTAGGAGTTAAAGCTAATTTTCTCT). The 
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PCR fragment was digested with NcoI and EcoRI, and ligated into pKEK894 (14) digested 
similarly. The new resulting plasmid was named pKEK1210 (pnadE). Cloning was performed 
into E.coli strain DH5α. F. tularensis subsp. novicida strains were grown on TSM (tryptic 
soybean media), TSAP (tryptic soybean agar plates) supplemented with 0.1% cysteine, 25 
mg/ml ferrous sulfate, 25 mg/ml sodium pyruvate, and 25 mg/ml sodium metasulfite, or on 
Chamberlain’s defined medium (CDM)(15). Antibiotics were used at following 
concentrations: kanamycin 50 µg/ml, and tetracycline 10 µg/ml. Plasmid pKEK1210 was 
transformed into ∆nadE mutant (tnfn1_pw060328p05q173) (13) via electroporation(16). 
Transformed bacteria were then plated on media selective for tetracycline. A selected clone in 
which the plasmid pKEK1210 was confirmed (PCR, plasmid digestion and sequencing) was 
denoted KKF302 (∆nadE + pnadE). 
 
In vivo assessment of NAD biosynthetic intermediates.  
F. tularensis strain U112 and B. anthracis strain Ames were grown in rich media (Trypticase 
Soy Broth and Luria Bertani, respectively) to log phase (OD600nm ~1) and harvested by 
centrifugation. To assess relative abundance of the NMN intermediate in the F. tularensis 
wild type and NadE* knockout mutant, cells were grown in defined medium (Chamberlain) 
with 200 uM nicotinamide. Perchloric acid (PCA) extraction of pyridine nucleotides was 
adapted from Maharjan et al. (17).  The cells were washed twice with cold PBS, followed by 
two cycles of freezing and thawing. Cells were then resuspended in 1:50 volume of MilliQ 
water, centrifuged, and extracted with 1:500 volume of 50% (V/V) ice-cold perchloric acid. 
After brief vortexing, the mixture was kept on ice for 15 min. Cell debris was removed by 
centrifugation, and supernatant was neutralized with 5N KOH; the resulting supernatants were 
removed and the extracts adjusted to pH 6.5. Extracts were aliquoted and stored at –20°C.  
NMN and NaAD intermediates were identified by HPLC analysis as described for the HPLC-
based assay. In order to provide an accurate quantisation of these metabolites, these samples 
were subjected to enzymatic depletion of NMN and NaAD content by using an excess amount 
of ftNadM and baNadE that would convert both intermediates to NAD in the proper buffer 
conditions. Total enzymatic depletion of intermediates was tested and optimized by adding 
exogenous NMN and NaAD at 100 uM in the presence or absence of the enzymes.  Net NMN 
and NaAD concentrations were determined by subtracting samples’ peaks from the 
corresponding peaks of the enzymatically depleted samples (see SI Fig. 11 for an example of 
NMN quantisation). For the enzymatic depletion of NMN and NaAD, 80 uL of extracts were 
diluted in 200 uL of buffer containing 50 mM Hepes (pH 7.5), 10 mM MgCl2, 4 mM NH4Cl, 








2   Tables and Figures 
SI Table 1. Functional reconstruction of NAD biosynthesis and salvage pathways in a 
set of selected bacterial genomes.  
From  NaMN to NAD 
De novo pathway: 
from Asp to NaMN 




          Route I Route II 
Salvage II: from  nicotinamide or 
nicotinamide ribose to NMN 
ASPOX QSYN QAPRT NAM NAPRT NaMNAT NADS NMNS          NMNAT RNK PnuC NMPRT 
Genome Variant 
nadB nadA nadC pncA pncB nadD nadE nadE nadM nadR nadR pnuC nadV 
Conventional NaMN-NaAD-NAD pathway with de novo biosynthesis (a) 
Escherichia coli K12  1.1.1.1 2545 736 109 1851 916 640 1723    4298 4298 737   
Erwinia carotovora 1.1.1.1 668 3569 2442 1996 1526 3358 844    4163 4163 3636   
Pseudomonas aeruginosa 1.1.1.1 762 1005 4524 4915 4916, 4914 4917      1957 1958   
Pseudomonas putida  1.1.1.1 1414 1221 778 2212 4803 4745 4804      2833 2834   
Pseudomonas fluorescens  1.1.1.1 4142 7219 2968   3208 7530 3207      7505 2549   
Bacillus anthracis 1.1.1.0 4305 4303 4304 155 557 4208 1831       190   
Vibrio cholerae  1.1.1.0 980 2724 872 1633 639 1344 1343       671   
Bacillus clausii  1.1.1.0 1509 1511 1510 429 3941 1602 2455          
Bacillus halodurans  1.1.1.0 1218 1220 1219 3777 3249 1326 2285          
Bacillus subtilis 1.1.1.0 2790 2788 2789 3179 3178 2567 314          
Carboxydothermus. 
hydrogenoformans 1.1.1.0 2555 2556 2554 539  604 1486          
Clostridium difficile  1.1.1.0 2477 2476 2478 3518 3067 2098 1853          
Desulfitobacterium sp. 1.1.1.0 293 2486 294 1173 916 3137 917          
Exiguobacterium sp.  1.1.1.0 271 269 270 1390 1389 2783 2691          
Geobacillus kaustophilus 1.1.1.0 2735 2733 2734 669 668 2614 2693          
Listeria monocytogenes  1.1.1.0 2014 2016 2015 2561 1084 1480 1085          
marine actinobacterium  1.1.1.0 2539 2540 2538 1403 1721 2605 1679          
Neisseria gonorrhoeae  1.1.1.0 1646 1645 1643 1749 472 1328 554          
Nocardia farcinica 1.1.1.0 1846 1845 1847 1119 1120 1404 4155          
Corynebacterium efficiens  1.1.1.0 ? 1116 1115 2385 2412 2257 2428          
Corynebacterium glutamicum 1.1.1.0 ? 366 365 1664 1668 2167 1682         
Fusobacterium nucleatum  1.1.1.0 602 601 603   932 1708 1778          
Bacillus B-14905  1.1.1.0 1935 1933 1934   853 1337 852          
Leifsonia xyli  1.1.1.0 ? 1096 1054   810 193 748             
Shewanella oneidensis 1.0.1.1 1244 2121 395     1087 1842        1809 
Alteromonas macleodii  1.0.1.0 2200 843 3806     1341 2177          
Helicobacter hepaticus  1.0.1.0 17 1839 1833     351 1008          
Thiomicrospira denitrificans  1.0.1.0 1610 2028 2029     1383 1142          
Pseudoalteromonas haloplanktis 1.0.1.0 790 1975 370     881 144          
Wolinella succinogenes  1.0.1.0 1467 1180 1179     625 191          
Shewanella sp. PV-4  1.0.1.0 3517 3630 2462     3656 327          
Colwellia psychrerythraea  1.0.1.0 4266 1627 4670     1581 3712          
Candidatus Pelagibacter  ubique 1.0.1.0 ? 1302 1301     1185 93          
Helicobacter mustelae  1.0.1.0 ? 1532 1533     1585 1209          
Helicobacter pylori 1.0.1.0 ? 1344 1343     1325 325          
Vibrio fischeri  1.0.1.0 2094 814 2184     3340 3341         3210   
Conventional NaMN-NaAD-NAD pathway without de novo biosynthesis (b) 
Oenococcus oeni  0.1.1.1      703 47 65 240    53 53 1055 813 
Lactococcus lactis  0.1.1.1      966 1132 1131 1134    2041 2041 2343   
Leuconostoc mesenteroides 0.1.1.1        120 793 121    98 98 99   
Streptococcus pneumoniae  0.1.1.0    2093 1437 1276 1590 1275       1672   
Streptococcus pyogenes  0.1.1.0    150 1368 1275 226 1274       1022   
Lactobacillus plantarum  0.1.1.0      2161 473 1268 474       468   
Campylobacter coli 0.1.1.0      1049 2028 1423 127          
Campylobacter jejuni  0.1.1.0      198 533 1624 851          
Campylobacter lari  0.1.1.0      468 45 682 331          
Campylobacter upsaliensis 0.1.1.0      977 1412 936 218          
Enterococcus faecalis  0.1.1.0      2980 2450 2676 2449          
ASPOX QSYN QAPRT NAM NAPRT NaMNAT NADS NMNS          NMNAT RNK PnuC NMPRT Genome Variant nadB nadA nadC pncA pncB nadD nadE nadE nadM nadR nadR pnuC nadV 
Mesoplasma florum  0.1.1.0      386 591 421 193          
Mycoplasma mycoides  0.1.1.0      996 653 417 415          
Lactobacillus acidophilus  0.1.1.0      1338 148 1525 149          
Oceanobacillus iheyensis  0.1.1.0      568 391 1985 392          
Pediococcus pentosaceus  0.1.1.0      1080 1171 1530 1172          
Staphylococcus aureus 0.1.1.0      2675 1782 1469 1781          
Tropheryma whipplei  str. Twist  0.1.1.0      692 623 469 405          
Tropheryma whipplei TW08/27  0.1.1.0      677 611 277 343          
Buchnera aphidicola 0.1.1.0        347 426 173          
Mycoplasma hyopneumoniae 0.1.1.0        491 375 372          
Mycoplasma penetrans  0.1.1.0        939 520 195          
Mycoplasma pulmonis  0.1.1.0        483 335 623          
Ureaplasma parvum serovar  0.1.1.0        280 476 467          
Mycoplasma genitalium  0.1.1.0          246 398        37 
Mycoplasma pneumoniae  0.1.1.0          336 563        47 
Flavobacteria sp. 0.1.1.0     1034     2549 1800       2195 2196   
Unconventional NaMN-NMN-NAD pathway (c) 
Francisella tularensis  Schu S4  1.0.2.1 1160 1162 1161         1334 933    164 1282 
Mannheimia succiniciproducens  0.1.2.1        1776     1775  164 164 185   
Actinobacillus succinogenes  0.1.2.1         ZP_00732388     ZP_00732389   ZP_00732632 ZP_00732632 ZP_00733245   
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SI Table 1 caption 
This condensed subsystem spreadsheet (modified from “NAD and NADP cofactor biosynthesis 
global” subsystem at http://anno-3.nmpdr.org/anno/FIG/subsys.cgi) shows gene patterns of 
NAD biosynthesis and salvage routes in a subset of representative bacterial genomes 
corresponding to those used for phylogenetic analysis of NadE family (“short” form without a 
glutamine amidotransferase domain (10) (18) (19). Rows indicate species with completely 
sequenced genomes integrated in The SEED database (except Actinobacillus succinogenes 
130Z, draft assembly at http://www.jgi.doe.gov), while genes and assigned functional roles 
within a metabolic pathway are shown as columns. Proteins are represented by abbreviated 
SEED identification numbers, except those for Actinobacillus succinogenes where IDs are 
provided as in NCBI (http://www.ncbi.nlm.nih.gov/); “?” - inferred by pathway analysis but a 
gene is unknown (cannot be projected by homology). Genes clustered on the chromosome 
(operons) are outlined by matching background colours. Genes (fusion proteins) encoding more 
than one functional role in the subsystem are underlined. The second column reflects a 
classification of organisms (genomes) using a four-number variant code. Each position of the 
variant code reflects the presence (usually 1 and in some cases “2” to capture alternatives) or 
absence (0) of a subsystem module (pathway) as it appears in the top row. Functional roles are 
abbreviated as follows: ASPOX, L-aspartate oxidase (EC 1.4.3.16); QSYN, Quinolinate 
synthetase (EC 4.1.99.-); QAPRT, Quinolinate phosphoribosyltransferase [decarboxylating] (EC 
2.4.2.19), NAMNAT, Nicotinate-nucleotide adenylyltransferase (EC 2.7.7.18); NMNAT, 
Nicotinamide-nucleotide adenylyltransferase of NadM or NadR family (EC 2.7.7.1); 
NMNAT_M, Nicotinamide-nucleotide adenylyltransferase, NadM family (EC 2.7.7.1); ADPRP, 
ADP-ribose pyrophosphatase (EC 3.6.1.13); NADS, NAD synthetase (EC 6.3.1.5); NMNS, 
NMN synthetase (EC 6.3.1.-); NAM, Nicotinamidase (EC 3.5.1.19); NAPRT, Nicotinate 
phosphoribosyltransferase (EC 2.4.2.11); NMPRT, Nicotinamide phosphoribosyltransferase (EC 
2.4.2.12); PNUC, Ribosyl nicotinamide transporter, pnuC-like; RNK, Ribosylnicotinamide 
















SI Table 2 | Conservation of NAD biosynthetic machinery among the 7 sequenced variants 
of F. tularensis deposited in GenBank. 
 
Genes implicated in NAD biosynthesis/salvage/recycling pathways of the eight sequenced 
strains of Francisella are shown by locus tags and genomes by GenBank Accession numbers. 
Enzyme abbreviations are described in the caption of SI Table 1. Numbers in brackets are the 
amino acid sequence identities (%) of NadE and NadM with respect to the enzymes of our 
reference strain, F. tularensis subsp holarctica LVS. Genes clustered in the chromosome are 
highlighted by the gray background. Schu S4, FSC198, and WY96-3418 belong to subsp 
tularensis; LVS, OSU18, and FTA to subsp holarctica, U112 to subsp novicida; This analysis 
suggests that all of these strains implement the same set of NAD pathways, including the novel 
NaMN→NMN→NAD pathway validated in this study for F. tularensis ssp holarctica.  
 
 
SI Fig. 1 | Conservation of NadE* enzymes among the 7 fully sequenced variants of             
F. tularensis deposited in GenBank. Multiple sequence alignment was performed using Muscle 
(25) and edited with Jalview (26). Positions with a percentage of identity above 90% are 
coloured-coded according to Clustalx (27)output standards. None of the few amino acid 
substitutions between the seven strains affect residues (marked by blocks, see text for 
description) that according to our 3D analysis could substantially contribute to catalysis or/and 
specificity.
De novo pathway, 
AspÆÆÆNaMN 


























FSC 198 AM286280 FTF1467c FTF1469c FTF1468c FTF1259 (100) 
FTF0386 
(99) FTF5134c (20) 
FTA CP000803 FTA_1475 FTA_1477 FTA_1476 FTA_0724 (99) 
FTA_0479 
(100) FTA_0613  
LVS AM233362 FTL_1388 FTL_1390 FTL_1389 FTL_0685 (100) 
FTL_0452 
(100) FTL_0579  
OSU18 CP000437 FTH_1350 FTH_1352 FTH_1351 FTH_0687 (100) 
FTH_0449 
(100) FTH_0579 (21) 
Schu 4 AJ749949 FTT1467c FTT1469c FTT1468c FTT1259 (100) 
FTT0386 
(99) FTT1534c (22) 
U112 CP000439 FTN_0694 FTN_0692 FTN_0693 FTN_1278 (99) 
FTN_0483 
(98) FTN_1443 (23) 
WY96-3418 CP000608 FTW_0631 FTW_0629 FTW_0630 FTW_0685 (99) 
FTW_1688 
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SI Fig. 2. NAD biosynthesis subsystem diagram. Functional roles are shown by 
abbreviations in boxes (as defined in Supplementary Table 1). Intermediates are shown by 
abbreviations in circles. Asp, L-aspartate; Trp, L-tryptophane, NA, nicotinic acid; NM, 
nicotinamide; NMR, N-ribosylnicotinamide; NaMN, nicotinate mononucleotide; NMN, 
nicotinamide mononucleotide; NaAD, deamido-NAD. Dashed arrows indicate multistep 
transformations. Thick coloured bars outline individual pathways present in F. tularensis (A), 
B. anthracis (B) and M. succinoproducens/A. succinogenes (C) as inferred by the presence or 



















































































SI Fig. 3 | SDS-PAGE of F. tularensis and B. anthracis enzymes.  
Analysis in 10 - 20% gradient SDS-PAGE of purified recombinant enzymes used for kinetics 
and pathway reconstitution studies :  Lane M, molecular weight standards; Lane 1, ftNadE*; ,  

















SI Fig. 4 | HPLC-based analysis used for kinetic studies of NadE enzymes and to monitor 
the entire pathway reconstitution. Standard separation of NaMN, NMN, NAD, NaAD, 
AMP, ADP and ATP (0.2-1 nmoles). The flow rate was 1 ml/min. Solvent A was a mixture of 
0.1 M potassium phosphate, pH 6.0 and 8 mM tetrabutylammonium bromide and solvent B 
was 30% methanol in buffer A. B,. The solvent gradient consisted of 3 min at 95% A, 2 min at 
up to 30 % B, 5 min at up to 60% B, 3 min at up to 100 % B, hold for 4 minutes, and then 








































































SI Fig. 5. Plots of initial rates versus substrate concentration obtained for ftNadE* (A),  
baNadE (B),  baNadD (C), ftNadM (D). Apparent kinetic parameters for the respective pyridine 
nucleotide substrates were determined at saturating ATP (for NMN-NaMN adenylyltransferase 
activity assays) or at saturating ATP and NH4Cl (for NaMN-NaAD synthetase assays). Data were fit to 
the Michaelis-Menten equation. Note that up to 20-30% substrate inhibition was observed for ftNadE* 
NMN synthetase activity at NaMN concentration above 3 mM. Therefore a limited data set (up to 1.2 
mM) was used for the approximation by a simple Michaelis-Menten model. Fitting the entire data set 
(up to 6.4 mM) using a substrate inhibition model resulted in similar Km and kcat values (data not 
shown). 















































































































SI Table 3 | C. glutamicum and H. pylori NadE substrate preference. 
Enzyme           NAD synthetase      NMN synthetase     Ratio 
      (U/mg)                        (U/mg)     
C. glutamicum NadE          3.27 ± 0.04  (0.76 ± 0.08) x 10 –3           4302 
H. Pylori NadE           0.19 ± 0.01                         (0.18 ± 0.03) x 10 –3       1055 
       
The relative substrate preferences were assessed for NadE enzymes from C. glutamicum and H. 
pylori by measuring their specific amidation activities at fixed 2 mM concentrations of NaMN and NaAD 
by HPLC analysis.  
SI Table 4. Crystal data and refinement statistics of ftNadE* complex 
Data statistics 
 
Space group P212121 
Cell dimensions a=50.43Å, 
b=126.45Å, 
c=152.54Å 
Resolution (Å) 50-1.85 
Total observations 294774 
Unique observations 79468 
Completeness (%) 94.0 (70.3)1 
Rsym2 on I 0.044 (0.356) 





Number of Protein atoms 7564 
Ligands 4 AMP, 4 PPi,  
8 Mg, 4 Na 
Number of waters  812 
Ave. B-factors (Å-1)  
             Protein 25.5 
             Ligands 19.1 
             Water 33.5 
Rmsd bond length (Å) 0.014 
Rmsd bond angle (º) 1.394 
 
1 The values in the parenthesis are for the highest resolution shells 1.92-1.85Å. 
2Rsym = Σhkl Σi |Ii (hkl) - <I(hkl)>| / Σhkl Σi Ii (hkl)  
3Rcryst = Σhkl ||Fobs| - k |Fcalc|| / Σhkl |Fobs|, where Fobs and Fcalc are the observed and calculated 
structure factors, respectively. 
4 Rfree is calculated the same way as Rcryst using randomly selected 5% of the reflections that 
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SI Fig. 6  Ligand binding in the 3D structure of NadE active site. A, The difference (Fo-
Fc) electron density for the bound ligand and metal ions in ftNadE* complex structure. The 
map is contoured at 3σ level. B, Stereo view of superimposed catalytic site in ftNadE* (cyan) 
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          SEC. STRUCTURE                                  hhhhhhhhhhhhhhhhhh     eeee      hhhhhhhhhhh                   eeeeee         hhhhhhhhhhhhhh    eeee       hhhhhhhhhhhhh                     
          F_tularensis  ..................MKIVKD....FSPKEYSQKLVNWLSDSCMNY..PAEGFVIGLSGGIDSAVAASLAVKTG...............LPTTALILPSDNNQ...HQDMQDALELIEMLNIE.HYTI...SIQPAYEAFLASTQSFTNL... 
  M_succiniciproducens  ............................MKTAAYADYLIQWLENQRTELY.GMDGYTLGVSGGIDSAVCAHLAARTG...............APVQALILPAEVTS...PSDVADAQATLESAGID.GQII...SIAPWYDLIMQQLSPVLNS... 
        A_succinogenes  ............................MRTAAYVDYLVRWLETQRTELY.GMDGYTLGVSGGIDSAVCAHLAARTG...............APVQALILPAEVTS...PEDVADAQITLESAGID.GRII...SIAPWYDLIMLQLTPALNA... 
                                                         33  37              51                                             
           SEC. STRUCTURE           hhhhhhhhhh            hhhhhhhhhhhhhhhhhh      eee      hhhhhhhhhhhhhhhhhhh         eeeeeeee            hhhhhhhhhhh   eeeee     hhhhhhhhhhhhh           
           B_anthracis  ........MTLQEQIMKALHVQPV....IDPKAEIRKRVDFLKDYVKKT..GAKGFVLGISGGQDSTLAGRLAQLAVEEIRNEGG......NATFIAVRLPYKV.....QKDEDDAQLALQFIQADQSVAF...DIASTVDAFSNQYENLLDE... 
            B_subtilis  ........MSMQEKIMRELHVKPS....IDPKQEIEDRVNFLKQYVKKT..GAKGFVLGISGGQDSTLAGRLAQLAVESIREEGG......DAQFIAVRLPHGT.....QQDEDDAQLALKFIKPDKSWKF...DIKSTVSAFSDQYQQETGD... 
                E_coli  ........MTLQQQIIKALGAKPQ....INAEEEIRRSVDFLKSYLQTYPF.IKSLVLGISGGQDSTLAGKLCQMAINELRLETGNE....SLQFIAVRLPYGV.....QADEQDCQDAIAFIQPDRVLTV...NIKGAVLASEQALREAGI.... 
              H_Pylori  ......................MQ....KDYQKLIVYLCDFLEKEVQKRG..FKKVVYGLSGGLDSAVVGVLCQKVFK..............ENAHALLMPSSVSM...PENKTDALNLCEKFSIP.YTEY...SIAPYDAIFSSHFKD....... 
                L_xyli  .......MRDLQARIIHELNVRAT....IDPAAEVVERVDFLVRYVRAAG..ASGFVLGVSGGQDSSLAGRLCQLAVERLAEQGV......AAEFIAVRLPYAV.....QNDEDDAQLALSFIRPERTVAV...NIQRGVEGVGNEYRDALGE... 
        D_Geothermalis  .......MLTLRDRIRQELHVRPE....IDPGAEVERRVAFLAKYLQHTP..ARGFVLGISGGQDSTLAGRLSQLAAERVRAEGG......DATFFAVRLPYGV.....QADEADAQTALGFIRPDRTLTV...NIKAAVDASARAVAEALGT[6] 
      Bacillus_B-14905  .....METMTLQQQIIEELRVQPT....IDAHEEIRKSIDFLKEYAKHYSF.VKGFVLGISGGQDSTLTGKLAQLAVDELNKEAG....MKEYSFWAIRLPYGV.....QADEQDCQDAIDYIKPTGSYTV...NIKDAVDASVRALANAGV.... 
             B_clausii  ......MMKVNQDSIRRDLHTKAD....IDPKEEIRTRVDFLKNYTRKAG..TKGFVLGISGGQDSTLAAKLAQMAVDELNQEAPG.....TYEFHAVRLPYGV.....QHDEKDAQVALSFIGPDKIHTV...NIKPAVDAAVASFAEATGE... 
    ExiGuobacterium_sP  ..........MQQEIIQVTGVKPV....IDAEEEIKQRVQFLKEYLVHTG..AKGLVLGISGGQDSSLAGRLCQIAVEELRSETNR.....DYQFYAVRLPYGQ.....QQDESDAQLALSFIRPDHALRV...DIKPAVAASMASFEQATGD... 
                O_oeni  .......MRLLQAKIIADLHVQPV....INAKDEIDRTIAFLKNYLIANPQ.YKSYVLAISGGQDSTLTGKLARIAINQLRQETG......NDQYEFIAVRQPYGE...QADEEDAQTALKFVAPDQTITT...NIKEATDALTKTLRVSGL.... 
            T_whiPPlei  ..........MCCDISKTLCVKPF....IDPEEEISHRVSFLADYLRHSR..ASGYVLGISGGQDSALAGRLCQIAVESVRSIGF......DATLWAIRLPYGQ.....QFDESDAQTAMQFISPDEELSF...DIRSATDNLCVDLNRSLGS... 
     C_Psychrerythraea  .........MNQQIIIAEMKVLPE....IDVQFEINRRVAFIKKQLVQSG..LTNLVLGISGGVDSSTCGRLAQLAVNELNGQLDEGEDKTHYQFIAVRLPYGI.....QADEDDAQQAVDFIQPSHCLTT...NVLAGADGIHHEVLQAMSKAQI 
         B_xenovorans_  ..MTHQDPAARQASISEEMHIGAT....FDAEYEIERRVTFLVSYLRGSG..LKTYVLGISGGVDSTTAGRLAQLAVEQLRAEH......YEAQFVAIRLPYGE.....QKDEADAQQALRFIRADQNLAI...DIKPAADAMLAALDRSGVLF.. 
              P_Putida  .......MQAVQQEIAQALKVQPPFADAAALEAEVARRVAFIKDCLANAR..LKTLVLGISGGVDSLTAALLAQRAINELRAETGD....KAYTFIAVRLPYQV.....QHDEHDAQACLEVIKADEVHTV...DIAPAVRALAAEVAALKNG... 
         P_fluorescens  ..........MQDRIARELNINRAL.VLGGEPEEIQRRIDFIKVTLRHSG..CKALVLGISGGVDSLTAGRLCQLAVQQLRSEA......YAARFIAMRLPYKT.....QADERDAQSSLDFITPDHIDTL...NIAASVDGLMASLTATDAS... 
         W_Glossinidia  ........MNTQKKIIKEFNVQPN....FEEKHEFERIKNFFISYLNKFSY.LRTLVLGVSGGQDSTLTGKICYEVIKEMKKKNNN....LNYKFIALRLPYGK.....QMDEIDCKLAIKFINPDKVIKI...NIKSAVKASVFSLKKSGI.... 
              S_aureus  .......MSKLQDVIVQEMKVKKR....IDSAEEIMELKQFIKNYVQSHSF.IKSLVLGISGGQDSTLVGKLVQMSVNELREEG......IDCTFIAVKLPYGV.....QKDADEVDQALRFIEPDEIVTV...NIKPAVDQSVQSLKEAGI.... 
          B_aPhidicola  ........MTLQKKIIELLGVKPA....IIPEIEIKNCVDFLKKYLVNHVH.IKSLIVGVSGGQDSTLTAKLCQMTAETLRKEKND....ITYQFIALRLPYGI.....QYDEKDCQDAIRFIQPDQIFNV...NIKKAVLSSEKSLKKSGV.... 
         N_Gonorrhoeae  ..............MMRIFSTGGK....MDTQAVITHIVRWLDEYAAQAN..AKGFVVGVSGGIDSAVVSTLAARTG...............RTTLLLDMPIRQH....PGQLERARRHIRNLQGQ.YANV[5]NLTDTFQTFEQTVGVHQTA... 
      Flavobacteria_sP  ............................MKVDKVTDHIVTWLKDYAIKAN..VKGYVVGVSGGIDSAVTSSLCAMTG...............LEVLCVEMPIHQH....HDHVTRAQEHIKQLKSR.FKNV[5]DLTPVFDTFIENMPDIKD.... 
        C_Pelagibacter  ............................MKPLEKAQFISNWIKDYVNKMPSKAQSLIIGISGGIDSSVSSTLSAMTG...............IKTIVLSMPIKQKSSQHDLSLKHQEWLVKNFDNVEAHTI...NLDKLFETFESTLSNF...... 
            M_Pulmonis  ..............MKSNTEIYKN...LKLLEDYGTYLIEWIKLKVQQAN..KKGVIVGISGGIDSALVACLAKKAFP..............ENSLGITMPIGNSM...KLDFDDIAKLQKLTKLE.IINI...DLTLSYDALAKTLDV....... 
            M_mycoides  ............MIMNWSEQTNMQ....TNLKQYLDYLVEFIQQTVKKAK..CNGVVVGISGGIDSAVVANLAKRAFP..............DNYLTVWMPIYSS....QLDYDCANELIKTNHLK.NIEV...NLETSFDAFKNSFSNLD..... 
           C_difficile  .......................M....SNIKIQIDKTVEWLINKVNEAN..AKGLIVGVSGGIDSAVVANLIKKAFP..............ENSMGVIMSIKSN....PQDREDALKVIEGCDIE.YLDL...DLIEPQSAILDMVVGNLKDKH. 
 Desulfitobacterium_sP  ....................MWSA....EELEIRINRAVEWLRERVQEAR..AQGLVIGVSGGVDSAVVAGLCKRAFP..............HNSIGVILPAGSN....PMDREDAWLATEALSLK.AVEI...DLTQAHQGILASVKKALTAQ.. 
    C_hydroGenoformans  ......................MR....VNWEEKTEKLVNWLREKTREAN..ASGLLVGLSGGVDSAVVATLIKKAFP..............EKSLGIIMPCFSN....PEDEEDARMIANHLNLK.YIVV...NLDEPYQALVSSLKNATP.... 
       M_hyoPneumoniae  ....................MINK....QDLINYFNYLIEWIRQEVKKAQ..KKGVIFGLSGGVDSALVAVLANKAFP..............DSHLGLIMPIRDM....ITDMVDIDLLVKKFGIK.NKEI...NLKPAFENLKKCFNL....... 
          M_Pneumoniae  ......................MT....KNLLNYLNELEAWLTNYVNEAH..AQGVVVGLSGGVDSAVVAAMTKKLFP..............QNHLTLVMHINNS....ELDHKATTALVEQLQLN.NKQV...DLEPPYRAMLQALTID...... 
           M_Penetrans  ......................MK....KDYIKIIDKIANWMNQTLTEAK..SNGFVYGVSGGIDSALICAIASKFF..............KDRSLAVRLDIFNS....VNDTKDANLVISHFKVN.SVDK...NLEQVFNTFIKDLP........ 
        W_succinoGenes  .....................MTL....TNPSALVNQLVDFLRQELAQRG..FKKVVVGLSGGVDSAVVARLCQEAIG..............ENLHALLMPSSVSS...KESVEHALLLCERFNLS.HHIQ...SIAPLELAFRELHPE....... 
           F_nucleatum  ...................MNKLD....LNLKEVHNELVEFLRENFKKAG..FSKAVLGLSGGIDSALVAYLLRDALG.............KENVLAIMMPYKSSN...PDSLNHAKLVVEDLKIN.SKTI...EITDMIDAYFKNEKE....... 
       T_denitrificans  .......................M....EKYAPIAEQLQHFLYEEVHKTG..IKNVVLGLSGGIDSAVVALLASRVFG..............DNLLCVKMPSHYSS...QSSLDDADEFSLAFNLR.SITS...SIEPMLKAYEEVNPD....... 
         C_uPsaliensis  ............................MDCEKILTKIQHFIQERVANAK..AKGVILGLSGGIDSALVATLCKKAL..............KDEVFALLMPTQHSN...EANLKDALKLCEDLNLK.YKII...NIETILQAFLKESEM....... 
                C_lari  ............................MNYTKLQELLINFIKEQARD.....ENLILGLSGGIDSALVAHLCKKAVG..............EKLFVLLMPTKYSK...KENLDDALMLCDHLQIH.HKII...YIDEVLCAYEKICQD....... 
            H_mustelae  .....................MQT....HFSPKSIQNILLFLKNTLQAKS..FHSVVLGLSGGIDSAVVAVLCKHAFP..............NTTLAISMPTLSSS...KQHLEDARILCEHFEIP.HIVH...SIAPYEEIFTRNEKDFDT.... 
           H_hePaticus  ..............................MKHFVNPCIHFIQKQLQERG..FKKVVLGLSGGIDSAVVATLATLALGS.............ENVRALLMPSLSSN...EEHFNDAFNLAHNLELE.SKII...QLAPFQENFAKQEGMDLSGKYM 
            T_maritima  .................................MKESLISFIKEKIEEYN..YRGAVVGVSGGVDSAVVLSLCVQALGK.............DRVFALILPERDSS...KDSLKDAVDFCERLGVE.YRKR...SITPILRKIGVYRLFPPR[27] 
marine_actinobacterium  .......MTPLQARIIYDLNTQPS....IDAAEQIRMRIDFLKEYLKTSH..AKGLVLGISGGQDSSLAGRLCQLAVAELRAEG......TEVQFVAVRLPHGV.....QHDEDDAQLALDFIEADREVTF...NIQRAVDGIAAEFADALGE... 
       C_michiGanensis  .......MRDIQSQIIDALEVRPT....IDPADEVRKRVDFLKAYLRSTG..AEGFVLGVSGGQDSSLAGRLAQLAVEELAAEG......LLAEFVAVRLPYGV.....QADEEDAQLALSFIQPKSSVVF...DIKRAVDGFQAEYADAAGH... 
           N_farcinica  .......MASLREQIITELGVQPV....IEPKTEVRRRVDFLKDYLRSTP..AQGFVLGISGGQDSTLTGRLCQLAAEEVRAEG......GEATFVAVRLPYGV.....QADEHDAAVAMEFIGPDRAVTV...NVKPGVDATAGAVAEGLGL... 
         D_radiodurans  MTPSPLPLSPLRSHIIRELHVQPD....IDPGAEVERRVAFLCDYLQSTP..TKGFVLGISGGQDSTLAGRLCQLAVERRRSQG......HGATFLAVRLPYGV.....QADEADAQQALDFIQADREVTV...NIKEAADASVAAAQAALGS... 
          C_Glutamicum  .......MTNTQTEIINELKVSPA....IDVAKEVEFRVQFLVDYLRASH..TKGFVLGISGGQDSTLAGRLTQLAVERIRAEENS....TDYVFYAVRLPYAI.....QADEDDAQVALEFIAPDKSVTV...NVKDATDATEATVAAALEL... 
           C_efficiens  ....MKTMTDTRDHIISQLSVVPS....IEPAAEVEARVQFLVDYLRVSH..ARGYVLGISGGQDSTIAGRLAQLAVERIRREDG.....SDHQFVGVRLPHGL.....QADEDDALVALDFIQPDRSISI...NIREATDVLSAATAAALGI... 
              U_Parvum  ......................MN....NDLIKYLQWLKNDFIKFLNDAQ..TNNVILGISGGIDSTLTLAILNDLKKEYD...........LNIYAYFLDIHN.....SSLDYECINELKNIYPN.IEVI...NLVDIYDSYCKMINKK...... 
         C_diPhtheriae  ..........MRNNIIHRLGTKPT....IDPATEIRNRVEFLTRYIKHSG..TKGFALGISGGQDSTLAGRLAQLAVEQLRVAG......YPAEFWAIRLPYGV.....QADEDDAHIALEFIQPDHSVVI...NIKEATDAAARATAQALGL... 
          S_Pneumoniae  ........MSLQETIIQELGVKPV....IDAQEEIRRSIDFLKRYLKKHPF.LKTFVLGISGGQDSTLAGRLAQLAMEELRAETGD....DSYKFIAVRLPYGV.....QADEADAQKALAFIQPDVSLVV...NIKESADAMTAAVEATGS.... 
            S_Pyogenes  ........MTLQEEIIRQLGVKAS....IDPQEEIRKAVDFLKAYLRKHSF.LKTYVLGISGGQDSTLAGKLAQMAIAELREEASD....QAYQFIAVRLPYGV.....QADEADAQKALAFIAPDQTLTI...NIKAAVDGQVEALQAAGV.... 
              L_lactis  ........MTLQDEIIKELGVKPV....IDPKEEIRVSVDFLKDYLKKYPF.IKSFVLGISGGQDSSLAGRLAQIAIEEMRQETAD....ETYKFVAIRLPYGV.....QADEEDAQRALAFIQPDVSLTV...NIKAAVEGQVAALNEAGI.... 
            E_faecalis  .......MTTLQEKIIQELGVLPT....IDPKEEVRKSIDFLKAYLTKHPF.LKTFVLGISGGQDSTLAGRLAQLAMTEMREETGD....MSYQFIAIRLPYGE.....QADEADAQAALAFIQPDVSLRV...DIKPAVDAMVGSLENAGV.... 
           L_Plantarum  .......MRPLQAEIIKALHVAPT....IDPEVEIRRSIDFLKAYLTKNTF.LKTYVLGISGGQDSTLAGKLTEMAITEMRQETGD....DRYQFIAVRLPYGN.....QADEADAMAAIDFMQADVTDRV...DIQPATDAMVTALEANQL.... 
         P_Pentosaceus  .......MRELQKEIIETLKVQPT....IDPKQEIRRSVDFMKNYLKKVPS.LRSLVLGISGGQDSTLAGALAEIAVRELREETGI....QDYRFIAVRLPYGV.....QADESDAMKAIEFMQADEVVRI...DIKPAADAMVAALEANDL.... 
         L_acidophilus  .......MRELQKEIIAYEHVLPE....IDPKKEIRRSIDFLKDYLKANPF.LKSYVLGISGGQDSTLTGKLCQMAIEEMREETGD....DSYQFIAVRLPYGV.....QADAADAADAVKFQNPDQDLIV...NIKEPVDAMVKVVEATGQ.... 
       L_monocytoGenes  ........MEIRERILADMQVAET....IDAHEEIRKSVEFLKAYLKKNTF.LKSFVLGISGGQDSTLTGKLAQMAISEMRAETGD....DEYRFFAVSLPYGT.....QLDESDRQDALNFMEPDNRLTV...NIKASVDASVAALAEAGV.... 
          E_carotovora  ........MSLQNDIITALGVKSS....IDPAQEIRVSVDFLKNYLNAHPF.ITSLVLGISGGQDSTLTGKLCQTAITELRNETGT....SRYQFIAVRLPYGV.....QADEADCQDAIAFIQPDRVLTV...NIKPAIESSEATLRAIGV.... 
           O_iheyensis  .......MSDLQKTIIEDLHVEPE....IDPKQEIRTRVDFLKSYLKKHTF.STGYVLGMSGGQDSTLLSKLTQIAVNELNEENST....NTYQFIGMKLPYGV.....QKDADDVDDAIKFVEPSKVLTV...NIKESVDASVKALDGAGV.... 
          B_halodurans  ..........MQQQIIKELHVSQM....VEPKEEIRKRVTFLKNYLKHSG..AKGYVLGLSGGQDSTLAGKLAQMAIDELNEEEQD....TSYVFIAVRLPYGV.....QKDEADAQDAIAFIKPSRSITV...NIKDAVDASTKSFEQATGE... 
       L_mesenteroides  .......MRPLQSKIIADLHVQPV....IGPNIEIKRSVNFLKQYLTHSA..YTGLAIAVSGGQDSTLAGKIGQLAIAELRAET.......NQKFEFVAIRQPYGE...QQDENDAQDALNFIKPDLTVTT...NIKDATDALVGSLRLGGL.... 
            V_fischeri  ..........MQQQIVEEMKVKVS....IDPVEEIKKRVDFIKGKLLEAH..CKSLILGISGGVDSTTCGRLAQLAVNELNLETQS....SDYQFIAVRLPYGI.....QQDEDEAQLALQFIQPTHSISI...NIKNGVDGLHSANHIALKDTGL 
            V_cholerae  ..........MEHKIREEMRVLPS....IDPQFEIERRVAFIKRKLTEAR..CKSLVLGISGGVDSTTCGRLAQLAVEELNQQHNT....TEYQFIAVRLPYGE.....QKDEDEAQLALSFIRPTHSVSV...NIKAGVDGLHAASHHALANTGL 
         Shewanella_sp  ..........MKGQIIREMKVQPH....IEVEYEVQRRIAFIKAKLKEAR..ATSLVLGISGGVDSSLAGRLCQLAVDELNSEGEYE...GSYQFIAVRLPFKV.....QKDEDEAQMACQFIQPSKLVTV...NIGEGVEGIHHQTLAGLEVAGV 
          S_oneidensis  ..........MKAQILREMKVLKA....IEPEFEVQRRVAFIKTKLKEAR..SKALVLGISGGVDSSTAGRLCQLAINSLNSEHPEG....GYQFIAVRLPYQI.....QKDEHEAQQACQFIQPSKLVTV...NVHQGVDGVHQATLSAFIDAGL 
        P_haloplanktis  ..........MRAEIMAAMKVQPV....IDVNAEISRRVNFIKARLIAAH..ATSLVLGISGGVDSSVCGRLCQLAVNELNQEQSTT....DYKFVAVRLPYGV.....QADENEAQLAVDFIQPSSRMTV...NIKPATDALHEQTMAAIVGNGE 
           A_macleodii  .........MQKQAVIDEMKVLPE....IDVEYEVARRVSFIKKQLLTSG..LNSLVLGISGGIDSCTLGRLAQLAVDELNEEHHET.....YQFIAVRLPYDT.....QADEEDAQKSIDFIQPTHSIAV...NVKPGADAIHASTSQALSDANL 
          S_coelicolor  ..MSEPASIALQKEIVRELEVAET....FDAEREIERRVAFLAERLTSTG..LRALVLGISGGVDSTTAGRLCQLAVERARAAG......HEALFYAMRLPHGV.....QADEDDAQQALSFIRPDRVLTV...DIKPASDAALDALLAADVAF.. 
        B_Pseudomallei  ..MSRPDQAARRRAIAAELHVSPT....FDARDEAERRIGFVADYLRTAG..LRACVLGISGGIDSSTAGRLAQLAVERLRASG......YDARFVAMRLPYGA.....QHDEADARRALAFVRADETLTV...DVKPAADAMLAALAAGGLAY.. 
             B_cepacia  ..MTSADYASRQRAIIAELNVAAH....FDVDAEITRRVDFLARYLRSSG..MRTYVLGISGGVDSSTAGRLAQLAVEQLRADG......YDARFIAMRLPNGV.....QNDEADAQRALAFVRADETFTV...DVKPAADAMLASLVASGHAF.. 
       R_leGuminosarum  ....MTVLFDEQGEIIRELGVAAD....IDPEREIERRTAFLKDYLVASG..MRGYVLGISGGVDSLTAALLAQKAVRELRDSG......HAAEFIAVRLPYGV.....QADEADAVKALETIGADRSMVV...NIKAPADAMLAAAQDGGLAF.. 
            P_syringae  .......MHAVQRQIAEQLKVQPPFADQNALQAEVARRVSFIKECLQNAR..LKTLVLGISGGVDSLTAGLLAQRAVKELRASTGD....NSYRFIAVRLPYVV.....QADEHEAQASVDFIEPDERHTI...NIGSSVKALAAEVKAFDGL... 
          P_aeruginosa  .......MQQIQRDIAQALQVQPPFQSEADVQAQIARRIAFIQQCLKDSG..LKTLVLGISGGVDSLTAGLLAQRAVEQLREQTGD....QAYRFIAVRLPYQV.....QQDEADAQASLATIRADEEQTV...NIGPSVKALAEQLEALEGL... 
              M_florum  ............................MELKEYLDYLVEFIKETVKKAN..AKGVVIGISGGIDSAVVACLAKKAFP..............NDYTAVWMPIESS....DEDYKCKQELIDQCGIK.AIDV...ELKETFLSFKKAIKDST..... 
        G_kaustoPhilus  ..............................MQEKIDKLVQWLRDQVSSAG..LNGAVVGISGGIDSAVVAHLIKRAFP..............DDSLGLIMPCKSN....PKDMEDALKVVKSCGIR.HLVI...DLTEAHRTLFGAVEAELKAIG. 
          M_Genitalium  .......................M....TNLIKYLKELQNWLFDYVKKSK..AKGVIFGLSGGIDSAVVAAIAKETFG.............FENHLALIMHINNS....KLDFQATSELVKKMQFN.SINI...ELEESFNLLVKTLGID...... 
              C_jejuni  ............................MDWQKITEKMCDFIQEKVKNSQ..SQGVVLGLSGGIDSALVATLCKRALK..............ENVFALLMPTQISN...KANLEDALRLCADLNLE.YKII...EIQSILDAFIKQSEN....... 
                C_coli  ............................MDCEKISQTLCEFIQHKVKDSG..LNGVVLGLSGGIDSALVATLCKKALG..............ENVFALLMPTKFSN...QENLNDALKLCQELNLK.YKII...EIQDILEAFLKQSEN....... 
                                                                   N             AAA  MA                                  A         A 
                                                                                                                  
                                                                                                                    “ P2 loop ” 
                                                                                                 
                                           124        133      142  147                    171                   193         202                      233 236 239        
                                   |          |        |    |                        |                     |           |                                   |  |  |                               
SEC. STRUCTURE                  hhhhhhhhhhhhhhhhhhhhhh   eeee  hhhhh h            eee      hhhhhhh        hhhh                       hhhhhhhh           hhhhhhhhhhhhh                           
F_tularensis   ......QNNRQLVIKGNAQARLRMMYLYAYAQQYNRIVIGTDNACEW.YMGYFTKFGDGAADILPLVNLKKSQVFELGKYLDVPKNILDKAPSAGLWQ...GQTDEDEMGVTYQEIDDFLDGK.....QVSAKALERINFWHNRSHHKRKLALT[3] 
  M_succiniciProducens  ......EPERVNVLKGNLMARLRMIALFTTAQSHRSIVLGTDNAAEW.LTGYFTKFGDGAADVLPLAGLRKEQVFELGRYLGVPQSVLDKKPSAGLWA...GQTDEAEMGVTYAEIDAYLRGE.....TVSPQALQQIRFWHNRSHHKRMLPPK[9] 
        A_succinoGenes  ......ESERINVLKGNLMARLRMIALFTTAQSHRSIVLGTDNAAEM.LTGYFTKFGDGAADVLPLARLRKEQVFELGRYLGVPKSVLEKKPSAGLWA...GQTDEGEMGVSYAEIDAYLRGE.....TVSPQALKQIQFWHNRSHHKRMLPPT[8] 
                              138        149      158  163                  187                   209         221                               252 255 258 
          SEC. STRUCTURE              hhhhhhhhhhhhhhhhhhhhhh   eeee  hhhhh h            eee       hhhhhhhh      hhhh               hhhh    hhhhhhhh           hhhhhhhhhhhhh              
           B_anthracis  ........SLTDFNKGNVKARIRMVTQYAIGGQKGLLVIGTDHAAEA.VTGFFTKFGDGGADLLPLTGLTKRQGRALLQELGADERLYLKMPTADLLDEKPGQADETELGITYDQLDDYLEGK.....TVPADVAEKIEKRYTVSEHKRQVPAS[7] 
B_subtilis  ........QLTDFNKGNVKARTRMIAQYAIGGQEGLLVLGTDHAAEA.VTGFFTKYGDGGADLLPLTGLTKRQGRTLLKELGAPERLYLKEPTADLLDEKPQQSDETELGISYDEIDDYLEGK.....EVSAKVSEALEKRYSMTEHKRQVPAS[7] 
                E_coli  ........ELSDFVRGNEKARERMKAQYSIAGMTSGVVVGTDHAAEA.ITGFFTKYGDGGTDINPLYRLNKRQGKQLLAALACPEHLYKKAPTADLEDDRPSLPDEVALGVTYDNIDDYLEGK.....NVPQQVARTIENWYLKTEHKRRPPIT[6] 
              H_Pylori  .........ASLTRKGNFCARLRMAFLYDYSLKSDSLVIGTSNKSER.MLGYGTLFGDLACAINPIGELFKTEVYELARRLNIPKKILNKPPSADLFV...GQSDEKDLGYPYSVIDPLLKDIE[16]GYDEILVKNITSRIQKNAFKLELPAI[7] 
                L_xyli  ........DMTDFAKGNVKARVRMVAQYAIAGQRRLLVVGTDHAAEA.VTGFYTKYGDGGADLLPLSGLSKRQGRALLQHLGAPARLYEKAPTADLLDQSPGQTDEANLGLRYSDIDDFLEGK.....DVAEKVAIAIEARYLATEHKRRVPAS[13 
        D_geothermalis  QPETTPHDPLRDFVRGNIKARERMVAQYAIAGQENLLVVGTDHAAEA.LTGFFTKYGDGGVDLTPLTGLTKRQGAQLLAFLGAPESTWRKVPTADLEDDRPGLPDEVALGVTYAQIDAYLEGR.....AVSPEVAARLERLYLATRHKRALPVT[8] 
      Bacillus_B-14905  ........QLNDFVKGNEKARERMKVQYSIAAMNGAVVLGTDHAAEA.ITGFYTKFGDGGADLMPIFRLNKRQGKQLLAELKCPEHLYMKVPTADLEENRPSLPDEVALGVSYDQIDDYLEGK.....EIPEEPRQLLEGYYLRSQHKRHMPIT[7] 
             B_clausii  ........ELSGFIKGNTKARERMKVQFDLAAHYQCLVLGTDHAAEA.VTGFFTKFGDGACDVIPLYGLTKRQGKALLQELGAPEALYQKIPTADLEDDKPGLPDEEALGMTYEQIDDYLEGK.....PIDSAIQEKLEQRYAATAHKRKDPVS[8] 
    ExiGuobacterium_sP  ........VLSDFSKGNTKARERMKVQYDIAAHYGCLVVGTDHAAEF.VTGFYTKHGDGACDLTPLTGLNKRQGKQLLRQLQAPEGLIEKVPTADLEDNQPGLPDEQALGMTYNEIDDYLEGK.....TISAESQAKLEAQYKRVGHKHHMPVS[7] 
                O_oeni  ........AADDMSRGSIKPKMRMIAQYAVAREHDGVVLGTDHAAEA.FAGFFTKYGDGGTDLDPLWRLDKSQGQQMLKALNAPESLYNKVPSADLEDKRPQLPDEVALGVKYKDIDKYLEGR.....EVSEEAAKQIEKLYLTTKHKRHLPVT[7] 
            T_whiPPlei  ........KISDFNRGNIKARLRMVVQYAVAAHHDALVVGTDHAAEA.VTGFFTKFGDGAADILPLYGLTKGQGRALLKALGACDSIIEKVPTADLLDDLPCLPDETELGLQYRDIDAFLEGK.....PVSEDITMAITERYKSTLHKRMPPIT[8] 
     C_Psychrerythraea  ...LTSSDAQIDFSKGNVKARARMVSQYHIAGIIGALVIGTDHSAEN.ITGFFTKWGDGACDLAPLFGLSKRQVRAIAKELGAPSILVDKAPTADLEELEPGKTDEDALGISYEQLDNFLEGK.....QVTTAVSEHIINIYKKTQHKRQAIPT[3] 
         B_xenovorans_  .....NDESHQDFVHGNIKARQRMIAQYAVAGARAGVVIGTDHAAES.VMGFFTKFGDGGADVLPLAGLNKRRVRAVAKALGAPEELAHKVPTADLEMLRPQRPDEDAYGIPYDAIDDFLEGK.....AVSDAARATILRYYDVTRHKRALPYT[11 
              P_Putida  ......SPTLVDFVVGNVKARTRMVAQYTIAGARAGLVIGTDHAAEA.VMGFFTKFGDGACDLAPLSGLVKNQVRAIARSFGAPESLVEKVPTADLEDLEPGKPDEASHGVTYAQIDAFLHGQ.....PVDQAAFDIIVATYRKTQHKRELPFAP.. 
         P_fluorescens  .......AEHVDFIKGNVKARTRMIAQYAVANLHNGLVVGTDHGAEA.LMGFFTKFGDGACDLAPLSGLTKTQVRLLASALGAPVNLVHKPPTADLEELAPGKLDEHAYACTYEEIDAYLMGE.....PVSERVKNIVERAYLKTAHKRALPIAPL. 
         W_Glossinidia  ........NITDHIKGNEKSRERMKVQYSVAGMTSGIVVGTCNAAES.ITGFFTKHGDSAVDLNPILHLNKRQVKKILIYLKCPKRLYSKIPTADLEDDRPGYPDEKSLGIKYDVIDDYLEGK.....IINLKMKNIIENLFEKTKHKRINQAL[7] 
              S_aureus ........ VLTDFQKGNEKARERMKVQFSIASNRQGIVVGTDHSAEN.ITGFYTKYGDGAADIAPIFGLNKRQGRQLLAYLGAPKELYEKTPTADLEDDKPQLPDEDALGVTYEAIDNYLEGK.....PVTPEEQKVIENHYIRNAHKRELAYT[7] 
          B_aPhidicola  ........IISDYVRGNEKARERMKVQYSIAAMKQGLVVGTGHAAEN.ITGFFTKYGDSGTDINPIAKLNKRQIRLLLKNLNCPKHLYLKKPMADLEDEHPQQDDESVLGVTYDAIDSYLEQK.....KIDIRSQKIIEALYLNTLHKRNLPITQ.. 
         N_Gonorrhoeae  .......FANQPLSLANARSRLRMLTLYYYGQIHGLLVTGTGNKVEDFGVGFFTKYGDGGVDISPIADLTKTQVYRLAEALGVDEAIQKAPPTDGLWD..TERTDEEQMGASYPELEWAMGVYG[8]PGRRREVLEIYTRLHRAMQHKINPIPV[9] 
      Flavobacteria_sP  .......SALVDLTRGNTRARLRMTTLYYHGGVNGLLVAGTGNKVEDFGVGFYTKYGDGGVDVSPIADLMKSHVYQIGKYVNVPESIMDAAPSDGLYG..AERTDEDQIGASYDELELIMNEIT[9]KGRMLEVFHLYLNLNKKNQHKMNPIPV[8] 
        C_PelaGibacter  .........DSELGMANSRARIRMTTLYQVAAANKGIVVGTGNKVEDFGVGFYTKYGDGGVDISPIADCNKSEVWEIGKSINILQEIIDAAPTDGLWD..DGRTDEGQLGLKYEELEEAMNN.......VNSINREKYEKIRKMNLHKMEPIPV[5] 
            M_Pulmonis  .........KNKLAKANIKPRLRMASLYAMAQEKDYLVLGTDNLDEW.YLGYFTKYGDGGVDLLPISYLTKSEVISLAQIYKVDKGIIEKKPSAGLWE...NQEDEKELGYSYSEVDLFLRKK.....QIDSQIATKIEKQHQMTEHKRQLASK[12 
            M_mycoides  .......EKPSLLAISNAKARLRMTTLYTIGQTKKYLVLGTDNLDEW.HIGYFTKYGDGGVDVVPIIHLLKSEVKKAAKILNVPELIINRKPTAGLWE...GQTDEGEIGFSYDLIDSYLLKQ.....NNDPKLKKRIDYLHKISKHKRSLAIK[6] 
           C_difficile  ....LYREEYLKMTDANLRARVRMSTIYTIANNLGYLVVGTDNAAEI.HTGYFTKFGDGGVDILPIANLTKGEVYEWAKELGVHEDLINKAPSAGLWE...GQTDEDEMGTTYNMIDAVLEGRL....EVPKRDQEIIERLHRLSEHKRKTPAQ[4] 
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 Desulfitobacterium_sp  .....EYTFEEQLSQGNLKARLRMSTLYTVANSLNYLVVGTDNAPEA.YTGYFTKYGDGGVDILPIASLTKAEVRAWAAQLGLPEKIVNRVPTAGLWE...GQTDEQEMGITYDLIDRYLLGE.....GVPEERQEKIEKMHQQSEHKRQLPPA[9] 
    C_hydroGenoformans  .......HEPEKLALANIKPRLRMTTLYYWAANLNYLVAGTGNRTEL.EIGYFTKWGDGGVDLLPIGNLTKTEVWEFARYLGLPEKIITKAPSAGLWE...GQTDEGEMGFTYKDIDHYLLTG.....EGSAELVDFVKRMQRKSQHKKRIPEVPML 
       M_hyoPneumoniae  .........KNKLANSNIQPRLRMTSLYAFAQEFDYLVLGTDNFSEM.YLGYFTKYGDGGVDLLPIVNLTKVQVWKMAAEIGIPESIIKKKPSANLWE...NQTDENEMGFSYGDLDLFMENPN....LVSKEIAAKITKLHEISSHKRDQIPR[8] 
          M_Pneumoniae  .......PQKELMVAGNLKARLRMACLYTHAQKHNYLVLGTGNFIEY.SLGYFTKWGDGACDVAPLAFLLKSDVYALSQHFNVPELVIERAPTASLFA...GQTDEAEMGLTYKELDQYFQGHL....QLSATKQQRVDHLRQSSQHKRSLPKT[7] 
           M_Penetrans  .........DNKLALMNLKSRLRMVCLYYYAQTYNYLVCGTSNADEL.YTGYFTKFGDSGSDFIPLANLTKTDVRECSKILGVPSQIINKDPSAGLFE...NQKDEDDLKVSYLEIDNFLENN.....PISESSKNRILDLHKISEHKRNMPKT[7] 
        W_succinogenes  .........ATPLRIGNACARFRMITLYDFSFKENRLVIGTGNKSEI.LLGYGTLYGDTACALNPIGDLYKTEIFQLAKFLSIPDEIIQKAPSADLFE...GQSDEKELGFSYNDMDQLLFDHI[12]GHAKELVEMVLKRISTNKFKSEMPPI[7] 
           F_nucleatum  .........ATSLRMGNKMARERMSILFDYSSKENALVVGTSNKTEI.YLGYSTQFGDAACALNPIGDLYKTNIWDLSRYLKIPNELIEKKPSADLWE...GQTDEQEMGLTYKEADQVMYRLL[12]GFNKDLVDNIVRRMNRSEYKRRMPLI[2] 
       T_denitrificans  .........MDNLRRGNLSARLRMSTLFDLSAKHNALVLGTSNKSEL.MLGYGTLYGDLACALNPIGDLYKSEVYELAEYLNVTNSIMKKAPSADLWA...GQSDEADLGYTYSQLDKVLKLYI[12]GYDAKMLDMIIERNLRNQFKGKMPLI[9] 
         C_uPsaliensis  .........TNQIRTGNYAARIRMSLLYDYSALKNYLVVGTSNKSEL.MLGYGTIYGDLACAFNPIGKLYKSEIYTLAKYLNLDVNFLQKAPSADLWE...NQSDEEDLGFSYTLIDEGLRALE[8]TKLNPRLISMLQKRTKQNAFKRVMPPI[6] 
                C_lari  .........LNPLRFGNLAARVRMSLLYDYSALHNALVVGTSNKSEL.MLGYGTIYGDLACAFNPLATLYKSEVFELAKFIGVHENFIQKAPSADLWP...NQSDEKDLGYKYEVLDEVLKALE[6].NFDENLKNLVLERVQNNAFKRKLPTT[8] 
            H_mustelae  .......PKPSALRLGNFLARIRMNILYDYSMQKNALVIGTSNKSEL.MLGYGTIYGDLAYAINPIGGFFKTEIFALAKALELPDSILTKEPSADLYP...DQSDAKELGYTYAQIDPLLEAIH[18]NFDAKMVEDITTRILKNCFKQKSPIIYQA 
           H_hePaticus  ....EKLDMNQKMRMGNFCARIRMTMLYDCASADNALVLGTSNKSEI.LLGYGTIFGDLAYAINPIGGLYKTQIFAFARALNVPQEIIAKKPSADLFA...NQSDETDLGYNYADIDTFLEAFE[23]GFECNMIESLSTRVWNNTFKRTKPTI[2] 
            T_maritima  LRNTGPEEFLKGLAYYRIKHRIRMCLLYFEAEKRGYAVVGTTNRTEY.LTGLYVKWGDEAVDIEPIMHLYKTQVFELAKEMNVPEKILKKPPSPDLIP...GITDEMAFNMSYLELDRILMKLE[3]SDEDPKKVERVKKILELSEKYRRDIPI[2] 
marine_actinobacterium  ........PITDFNKGNVKARERMVAQYAIAGQLGYLVVGTDHAAEA.VTGFFTKFGDGGADVLPLSALTKRQGKQLLKHLNAPERLYEKVPTADLLDHTPGQADEDNLGVTYEHIDDYLEGR.....DVPAEVAVEIETKYLNSRHKRTVPVS[5] 
       C_michiGanensis  ........AMTDFTKGNVKARSRMIAQYALAGQARLLVIGTDHAAEA.VTGFFTKYGDGGADVLPLTGLTKRQGRALLERLGAPERLYLKAPTADLLDETPGQTDEANLGLTYADIDDFLEGR.....DVDDEVAEAIEARYASTEHKRRVPAS[3] 
           N_farcinica  .......DALRDFVRGNIKARERMIIQYAIAGQENLLVVGTDHAAEA.VTGFFTKYGDGGVDLTPLTGLTKRQGAALLQELGAPPSTWSKVPTADLEDDRPALPDEEALGLRYSEIDDYLEGK.....EVTEAVAARVEQLYTATRHKRTVPVS[3] 
         D_radiodurans  ........EVRDFVRGNVKARERMVAQYALAGQENLLVVGTDHAAEA.LTGFYTKYGDGGVDLTPLSGLTKRQGAQLLAHLGAPEGTWRKVPTADLEDDRPGLPDEVALGVTYAQIDAYLEGR.....EVSDEAAARLERLFLNSRHKRALPVT[16 
          C_Glutamicum  .......PELTDFNRGNIKARQRMVAQYAIAGQLGLLVIGTDHAAEN.VTGFFTKFGDGAADLLPLAGLSKRQGAAILEHLGAPSSTWTKVPTADLEEDRPALPDEEALGVSYADIDNYLENKP....DVSEKAQQRIEHLWKVGQHKRHLPAT[7] 
           C_efficiens  .......DELGDFNKGNVKARQRMVAQYAIAGELGLLVVGTDHAAEN.VTGFFTKYGDGAADVLPLAGLTKRQGALLLQHLGAPESTWTKVPTADLEEDRPALPDEEALGVTYREIDTYLENSG....EVSPEAAARIEHLWKVGQHKRHMPVT[8] 
              U_Parvum  ........TNDKYVLYNLKPKIRTNYLYAMANAYKGVVVSNLNYDEY.ILGFFTKYGDSAADYYMLIGLLKKHIYELGAYYHLPNKILNRAPTPANEDD.EHKTDESFFGFTYNDLDQFLLYR.....KINPKIVSMIKKRYETNAHKHFVFDK[14 
         C_diPhtheriae  .......QDVGDFNKGNIKARQRMIAQYALAGEKKLLVIGTDHAAEN.VTGFFTKFGDGGADILPLAGLSKRQGAALLEHLGAPASTWEKVPTADLEEDRPALPDEEALGVTYREIDAYIEGNE....EVSPEAQQRIERLWKIGQHKRHLPVE[7] 
          S_Pneumoniae  ........PVSDFNKGNIKARCRMIAQYALAGSHSGAVIGTDHAAEN.ITGFFTKFGDGGADILPLYRLNKRQGKQLLQKLGAEPALYEKIPTADLEEDKPGLADEVALGVTYAEIDDYLEGK.....TISPEAQATIENWWHKGQHKRHLPIT[7] 
            S_Pyogenes  ........EISDFNKGNIKARQRMISQYAIAGQMAGAVIGTDHAAEN.ITGFFTKFGDGGADILPLFRLNKRQGKALLKVLGADAALYEKVPTADLEDQKPGLADEVALGVTYQDIDDYLEGK.....LISKVAQATIEKWWHKGQHKRHLPIT[7] 
              L_lactis  ........EVSDFNKGNIKARQRMITQYAVAGQYQGAVLGTDHAAEN.ITGFFTKFGDGGADLLPLFRLNKRQGKALLAELGADPAIYEKVPTADLEEGKPGLADEIALGVTYNDIDDYTEGK.....VISEDAKAKIEAWWKKTQHKRHLPIS[7] 
            E_faecalis  ........QISDFNKGNMKARQRMITQYAVAGENAGAVIGTDHAAEN.VTAFFTKYGDGGADILPLFRLNKRQGKALLKELGAPEALYLKIPTADLEDDKPLVADEVALGVTYDAIDDYLEGK.....KVSETDQQTIENWYKKGQHKRHLPIT[7] 
           L_plantarum  ........TIHDFNKGNIKARQRMIVQYGIAGEMHGAVVGTDHAAEA.VTGFYTKYGDGGADIVPLWRLNKRQGKQMLAALDAPKHLYDKVPTADLEEDRPALPDEVALGVRYDDIDDYLEGR.....TVSDAAAEKIEAWYLKTAHKRHAAIT[7] 
         P_Pentosaceus  ........KISDFNKGNIKARERMIAQYGIAGSNAGIVIGTDHAAES.VTGFYTKFGDGGADIIPLWRLDKRQGKAMLKELNAPVELYEKTPTADLEEERPALPDEVALGVTYDDIDNYLEGR.....EISSEAADKIEGWYKRTAHKRVLPYT[4] 
         L_acidophilus  ........KITDFNKGNIKARQRMVVQYAIAGANNGAVVGTDHAAEN.FSGFYTKYGDGAADLTPLFRLDKRQGKMLLKELGCPKHLYEKAPTADLEEEKPDLPDEVALGVTYEEVDDYLEGK.....EVSEKAADQIEKLWNKSKHKRHLPVT[7] 
       L_monocytogenes  ........ELSDFAKGNEKARERMKVQYAIAAMHKGVVVGTDHSAEA.VTGFYTKYGDGGTDINPLFRLNKRQGKALLKELGCPEHLYLKKPTADLEDNKPALPDEVALGVTYDQIDDYLEGK.....EVPADAAAKIENWFIKTEHKRHMAIT[7] 
          E_carotovora  ........ELSDFVKGNEKARERMKAQYSIAGMNAGLVVGTDHAAEA.VTGFFTKYGDGGTDINPIFRLNKRQGKALLRELGCPSHLYTKAPTADLEEDRPSLPDEVALGVTYEKIDDYLEGK.....PIDANDAATIENWYRKTEHKRRPPIT[7] 
           O_iheyensis  ........EISDFLKGNEKARERMKAQYSVAGAFNCFVLGTDHAAEA.VTGFYTKHGDGACDLAPLFGLNKRQGKQMLVALNCPEHLYNKKPTADLEDDRPALPDEEALGVTYEQIDEFLEGK.....EVAEDSKRTIEGHYLKTMHKREGEVT[7] 
          B_halodurans  ........VLSDFNKGNTKARERMKAQYDVGAHYGCLVIGTDHAAEA.ITGFFTKHGDGACDVAPLFGLTKRQGKSLLKELGAPTHLYTKAPTADLEDDRPGLPDEEALGLTYEQLDDYLEGK.....QVHDAIRKKIESRYLATEHKRQLPVT[7] 
       L_mesenteroides  ........TVDDMSRGSIKPKVRMIAQYAVAREHNSAVIGTDHAAEA.VAGFFTKYGDGGTDINPLWRLNKRQGRQLLEALHAPKHLYDKVPTADLEDERPQLPDEVALGVRYDVIDDYLEGK.....DVANTDAERIEEMYLTTQQKRHEPIT[7] 
            V_fischeri  ...LPTDSAKIDFVKGNVKARARMIAQYEVAGYVGGLVLGTDHSAEN.ITGFYTKFGDGACDLAPLFGLNKRQVREVAAQLGAPEQLVKKVPTADLEELAPQKADEDALSVSYDQIDDFLEGK.....KIDADAEDRLIKIYQMSQHKRKPIPTIYD 
            V_cholerae  ...IPSDPAKVDFIKGNVKARARMVAQYEIAGYVGGLVLGTDHSAEN.ITGFYTKFGDGACDLAPLFGLNKRQVRLLAKTLGAPEQLVYKTPTADLEELAPQKADEAALNLTYEQIDDFLEGK.....AVPAEVSQRLVAIYHATQHKRQPIPTIYD 
         Shewanella_sP  ...ISHPHSNVDFVKGNVKARMRMIAQYEIAGLTGGLVVGTDHSAEN.ITGFYTKWGDGACDLAPLFGLSKRQVRQLAAALGAPSVLVDKAPTADLECDKPQLEDEVALGLTYDQIDDFLEGK.....PVDAAVEARLIAIYNATQHKRKPIPTLYD 
          S_oneidensis  ...TTPDAAKVDFIKGNVKARMRMIAQYELAGLVGGLVVGTDHSAEN.ITGFYTKWGDGACDLAPLFGLNKRQVRQLAAYLGAPESLVYKAPTADLEDNKPLLEDEVALGLTYEQIDDFLEGK.....VVDKAVEEKLINIYKATQHKRQPIPTIYD 
        P_haloplanktis  ...SLPEQEKIDFIKGNVKARQRMIAQYEIAAFCQGLVVGTDHSAEN.ITGFYTKFGDGACDLAPLFGLSKRQVRALGSTLGASSVLVNKAPTADLESDRPGLTDEEALGLSYEQIDDFLEGK.....PVTQQVEQTLSAIYQRTQHKRQPVPT[5] 
           A_macleodii  ...LPESEAKQDFVKGNVKARTRMVIQYEIAGMVDGLVLGTDHSAEN.ITGFYTKYGDGACDLAPLFGLSKRQVRAVAAHLGAPHNVITKAPTADLESLSPQKADEQALGMSYDQIDDFLEGK.....HVSAEVEEKLLYIYERTQHKRVPIPT[5] 
          S_coelicolor  .....RDPHHQDFVHGNIKARQRMIAQYAVAGAHGGLVVGTDHAAEA.VSGFFTKFGDGAADVVPLTGLTKRRVRAVGDALGAPAALVRKVPTADLETLDPGKADEDALGVTYEEIDDFLEGK.....PVTEQVFETIVTRYRQTDHKRRLPIAP.. 
        B_Pseudomallei  .....LDHAQQDFVLGNIKARERMIAQYAVAGARNGVVIGTDHAAES.VMGFFTKFGDGGADVLPLAGLTKRRVRALARMLGADEPLVLKTPTADLETLRPQRPDEHAYGITYEQIDDFLEGK.....PMDDAVAETVLRFYDATRHKRALPYT[9] 
             B_cepacia  .....ETAAQQDFVHGNIKARERMIAQYAVAGARRGIVIGTDHAAES.LMGFFTKFGDGGADVLPLAGLSKRRVRAVARALGGDELIVMKVPTADLEELRPLRPDEHAYGVTYDEIDDFLEGK.....PVSDNVYETVLRFYDGSRHKRALPYT[9] 
       R_leguminosarum  .....ADAGRQDFILGNIKARQRMIAQFALAGALGSLVIGTDHAAEA.VMGFFTKFGDGAADILPLAGLNKRRVRLLAKRLGAPDELVFKVPTADLEDQRPLRPDEEAYGVSYDEIDDFLEGK.....PVGEIARRRILAAYRATAHKRALPVA[4] 
            P_syringae  ......PASSVDFVLGNTKARMRMVAQYTVAGAYQGLVIGTDHAAEA.VMGFFTKFGDGACDLAPLSGLVKNQVRAIARHFGAPESLVEKVPTADLEDLSPGKPDEASHGVTYAEIDAFLHGE.....PVREEAFKIICETYAKTQHKRELPYAP.. 
          P_aeruginosa  ......EPAKSDFVIGNIKARIRMVAQYAIAGARGGLVIGTDHAAEA.VMGFFTKFGDGACDLAPLSGLAKHQVRALARALGAPENLVEKIPTADLEDLRPGHPDEASHGVTYAEIDAFLHGQ.....PLREEAARVIVDTYHKTQHKRELPKAP.. 
              M_florum  .......TPEHKLAIANAKARLRMTTLYTVAQTNSYLVLGTDNLDEW.HIGYFTKFGDGGVDMVPLVHLLKREVREAARILGVPTSIINRAPTASLWE...DQTDESELGITYDQIDAYLAGE.....INDENVKSRVDHLHKISEHKRNGAVA[7] 
        G_kaustophilus  ....EWSEERARLGDANTRARLRMTTLYAVANNYGYLVVGTDNAAEW.HTGYFTKYGDGGVDLVPLIHFTKGEVREMGRLLGVPEEIIKKAPSAGLWE...GQTDESEMGTTYEMIDKYLKGE.....DIPERDRKIIERLHERSHHKRQLAIA[4] 
          M_Genitalium  .......PKKDFLTAGNIKARLRMITLYAYAQKHNFLVLGTGNFVEY.TLGYFTKWGDGACDIAPLAWLLKEDVYKLAKHFNIPEIVITRAPTASLFE...GQTDETEMGITYKELDQYLKGDL....ILSSEKQKIVLDLKAKAEHKHNSPLK[9] 
              C_jejuni  .........TTLVSLGNFAARIRMSLLYDYSALKNSLVIGTSNKSEL.LLGYGTIYGDLACAFNPIGSLYKSEIYALAKYLNLHENFIKKAPSADLWE...NQSDEADLGFSYAKIDEGLKALE[7]RTLDPSLIAMLKNRMQKNAFKGKMPEILEI 
                   C_coli   .........TDELSRGNFAARIRMSLLYDYSALKKALVVGTSNKSEL.LLGYGTIYGDLAYAFNPIGELYKSEIYGLARYLNLNEKFIQKAPSADLWI...GQSDEKDLGFSYELIDKGLKALE[7]ENLDKKLLDMLQSRIKNNAFKRNMPEI[5]               
                                        N   N A    N        N   A    M     N NN      N        A                     M  N        M                                         NN          
 
 
SI Fig. 7 | Multiple sequence alignment of representative bacterial NadE enzymes. 
Complete organism names for all NadE representatives are provided in SI Table 1. Those with 
known 3D structure are underlined. The signature “P-loop” motif residues  are highlighted in 
black. Locations of secondary structure elements are marked for ftNadE* and bsNadE with 
“h” for helix and “e” for strand. Conserved small or polar residues are highlighted in gray. 
Uncharged residues in mainly hydrophobic sites are highlighted in yellow. Residues that 
interact with ATP, NAD, or metal ions are indicated by letter A, N or M, respectively, at the 
bottom of the alignment. Residues that are different between ftNadE* and bsNadE in their 
adenosyl binding site (shaded by cyan) and nicotinosyl binding site (shaded by green) are 






















SI Fig. 8 | Maximum-likelihood phylogenetic tree of bacterial NAD synthetase family. 
Constructed based on 67 bacterial representatives of NadE family that do not contain a 
glutamine-amidotransferase domain (reduced from the original set of ~200 sequences by a 
single linkage clustering method with 75% identity threshold to decrease redundancy). Color 
coding denotes major taxonomic groups: α-proteobacteria (magenta), β-proteobacteria (red), 
γ-proteobacteria (cyan), ε-proteobacteria (orange), Bacillus/Clostridium group (dark blue), 
Mycoplasmatales (brown). Experimentally characterized NAD synthetases with solved 
tertiary structures are marked by “3D”. A distinct NMN synthetase branch containing F. 
tularensis NadE and two orthologs from M. succinoproducens and A. succinogenes is outlined 
by grey background. An approximate branching point for a more divergent group of NAD 
synthetases containing an additional glutamine-amidotransferase domain (NADS-GAT)  is 














SI Fig.9 | Direct verification of ftNadE* catalyzed conversion of NaMN to NMN. 
(A) direct verification of novel NMN synthase activity of F. tulariensis nadE gene 
product. Shown are the HPLC (traces at 254 nm) of reaction mixtures containing 2 mM 
ATP, 1 mM NaMN, 4 mM NH4Cl, 10 mM Mg2+ in the absence or presence of 4 uM  
ftNadE* after 1 h of incubation. Positions corresponding to NMN and AMP products 
are indicated by arrows. (B) The proposed mechanism of reaction catalyzed by NMN 











Scheme 1. An enzymatic system described by the model (1) – (4). The system is 
analyzed for two important organisms, Francisella tularensis (organism F) and Bacillus 
anthracis (organism B), see the main text for more details. Here A is the universal 
nicotinic acid mononucleotide precursor (NaMN), B is nicotinamide mononucleotide 
intermediate (NMN), C – nicotinic acid dinucleotide (NaAD), D – nicotinamide 
adenine dinucleotide (NAD). Reaction 1 is catalyzed by NMN synthetase (ftNadE), 
reaction 2 is catalyzed by NMN adenylyl transferase (ftNadM), reaction 3 is catalyzed 
by NaMN adenylyl transferase (baNadD), and reaction 4 is catalyzed by NAD 
synthetase (baNadE). V0 is an influx into the open system; the pathway is modelled as a 
closed system (e.g. a test-tube) when V0 is absent (i.e. when V0 = 0 and the utilization of 
D is absent). Route I, AÆCÆD, and Route II, AÆBÆD, corresponds to Route I and 
Route II depicted in Fig.1 of the main text, respectively. 
 













№ Enzyme Name Reaction Rate
1 NMN synthetase
2 NMN adenylyl- 
transferase




















































































Parameters Francisella tularensis Bacillus anthracis
k 1 (1/sec) 0.5 0.004
K 1 (mM) 0.2 1.18
k 2 (1/sec) 2.8 0.014
K 2 (mM) 0.034 0.94
k 3 (1/sec) 0.16 25.6
K 3 (mM) 0.81 0.04
k 4 (1/sec) 0.25 2.64





















































































































































SI Figure 10. Transient processes for the metabolite concentrations for organism 
F. (a), (b) [E1] : [E2] = 10 : 1, [E1 ] = 4·10-3 (mM); (c), (d) [E1] : [E2] = 1 : 1, [E1 ] = 4·10-



















SI Fig. 11. Transient processes for the metabolite concentrations for organism B. 
(a), (b) [E1] : [E2] = 10 : 1, [E1 ] = 4·10-3 (mM); (c), (d) [E1] : [E2] = 1 : 1, [E1 ] = 4·10-3 


































































































































































SI Table 7. Steady state concentrations and fluxes in organisms F and B. 
 
 
Organism F Organism B 
1. E1=0.004 (mM) and E2 = 0.0004 (mM) 
concentrations             fluxes 
 
concentrations              fluxes 
[A] = 0.20   (mM)          V1 = 9.99·10-4 (mM·s-1) [A] = 4.38·10-3 (mM)    V1 = 5.35·10-8 (mM·s-1) 
[B] = 0.35   (mM)          V2 =  9.99·10-4 (mM·s-1) [B] = 1.02·10-2 (mM)    V2 =  5.44·10-8  (mM·s-1) 
[C] = 0.016 (mM)          V3 = 1.37·10-6 (mM·s-1) [C] = 3.04·10-2 (mM)    V3 = 1.00·10-3 (mM·s-1) 
[D] = 1.00   (mM)          V4 = 1.37·10-6 (mM·s-1) [D] = 1.00         (mM)   V4 = 1.00·10-3 (mM·s-1) 
2. E1=0.004 (mM) and E2 = 0.004 (mM)  
[A] = 0.20   (mM)          V1 = 8.83·10-4 (mM·s-1) [A] = 3.95·10-4 (mM)    V1 = 4.84·10-9 (mM·s-1) 
[B] = 0.36   (mM)          V2 =  8.83·10-4 (mM·s-1) [B] = 8.50·10-5 (mM)    V2 =  5.02·10-9  (mM·s-1) 
[C] = 1.53 (mM)            V3 = 1.17·10-4 (mM·s-1) [C] = 3.03·10-2 (mM)   V3 = 1.00·10-3 ((mM·s-1)) 
[D] = 1.00   (mM)          V4 = 1.17·10-4 (mM·s-1) [D] = 1.00        (mM)   V4 = 1.00·10-3 (mM·s-1) 
3. E1=0.0004 (mM) and E2 = 0.004 (mM)  
The concentrations of metabolite C becomes  [A] = 3.94·10-4 (mM)   V1 = 2.84·10-11 (mM·s-1) 
very large, [C] > 100 (mM)  [B] = 4.81·10-7 (mM)   V2 =  2.84·10-11 (mM·s-1) 
while [D] = 1 (mM). [C] = 5.18         (mM)   V3 = 1.00·10-3   (mM·s-1) 

















SI Fig. 12.Complete HPLC traces of NAD pathway reconstitution experiments. 
Individual chromatograms of pathway reconstitution experiments presented in Fig. 
3c,3d and performed as described in Methods.  Upper, middle and lower traces show 
progression of in vitro NAD biosynthesis at time 0, 30 and 60 minutes in Francisella 
tularansis [(A), NaMNÆNMNÆNAD] and Bacillus anthracis systems [(B), 
NaMNÆNaADÆNAD]. Peaks corresponding to pathway intermediates, NMN and 
NaAD, are indicated by dotted vertical lines. An extra peak corresponding to ADP 







































































































































































































SI Fig. 13. In vivo assessment of NAD intermediates. Shown are partial HPLC 
profiles of NAD biosynthetic intermediates in extracts of F. tularensis strain U112 prior 
(blue) and after (red) enzymatic depletion of NMN (*) by NMN adenylyltrasferase.  A 
subtracted profile (green) enables an accurate quantitation of cellular NMN amount. A 
similar strategy, with an excess of NAD synthetase as a metabolite-depleting enzyme 






SI Fig.14. Measurement of NMN synthetase activity in crude extracts of F. 
tularensis strain U112: comparison between WT and NadE*  knockout mutant. 
Incubation of  70 ug total protein extract with 1 mM NaMN, 2 mM ATP and 4 mM 
NH4Cl yelds accumulation of NMN intermediate over time, while no formation of 
NMN is detected for the ftNadE* knockout mutant. This result confirms the in vivo 






Phylogenetic distribution and a possible evolutionary scenario of the newly identified 
NMN synthetase 
The phylogenetic distribution of the newly identified NMN synthetase, a signature 
enzyme of the Route II (NaMNÆNMNÆNAD) pathway, appears to be rather limited. 
A comparative sequence analysis of  all representatives of the NadE family from the 
650 completely sequenced genomes integrated in The SEED allowed us to identify only 
two additional representatives of the NadE* branch beyond the seven strains of F. 
tularensis. As can be seen from the simplified tree (SI Fig. 8) of single-domain 
members of the NadE family in bacteria (same as those included in the NAD subsystem 
in SI Table 1 and in the multiple alignment in SI Fig. 7), a relatively well-separated 
NadE* branch contains the proteins from two species of the Pasteurellaceae group, 
Mannheimia succinoproducens and Actinobacillus succinogenes. Amino-acid sequences 
of both Pasteurellaceae enzymes are generally close to the sequence of ftNadE* (54% 
identity) and share with it a number of residues listed above as part of an NMN 
synthetase signature contributing to its unique substrate preference.  
Colocalization of M. succinoproducens and A. succinogenes nadE* genes in the 
same operon with the pncB gene encoding nicotinate phosphoribosyltransferase 
suggests that together these two enzymes may compose a new variant of the nicotinic 
acid (Na) salvage pathway (SI Fig. 2). In this pathway, Na would be transformed to 
NaMN by the PncB enzyme, followed by the amidation of NaMN to NMN 
intermediate, which would then be converted to the NAD cofactor by the NMN 
adenylyltransferase of the NadR family. The latter enzyme was previously characterized 
as the only housekeeping adenylyltransferase in H. influenzae (9). The NMN 
adenylyltransferase and the RNm kinase (encoded in the C-terminal domain of the 
NadR protein) activities together with the PnuC transporter compose the RNm salvage 
pathway that is present in all Pasteurellaceae, including M. succinoproducens and A. 
succinogenes. However, the presence of pncB and nadE homologs is the unique feature 
of the latter two strains. Identification of a similarly organized pncB-nadE operon in 
some Gram-positive bacteria suggests a possible evolutionary scenario that involves its 
horizontal transfer to a common ancestor of M. succinoproducens and A. succinogenes. 
As most of NAD biosynthetic machinery (including the NaMN adenylyltransferase of 
29 
 29
NadD family) was lost in the common ancestor of all Pasteurellaceae, the NAD 
synthetase activity of the acquired conventional NadE enzyme would not give any 
competitive advantage. It is tempting to speculate that a fully functional NMN 
synthetase could have evolved in this genetic background starting from a low side-
activity of the acquired (and otherwise obsolete) NAD synthetase enzyme. It is 
conceivable that an evolved nadE* gene could become a subject of further horizontal 
transfer events, e.g., to an ancestor of F. tularensis. A combination of NMN synthetase 
with NMN adenylyltransferase (of the NadM family) would enable an alternative NAD 
biosynthetic route and allow the elimination of the functionally redundant conventional 
pathway from F. tularensis. Although the proposed evolutionary scenario is highly 






Comparison of the chromosomal arrangement of the nadE* and nadE genes.  In 
both members of Pasteurellaceae group, the gene nadE* occurs in the operon-like 
chromosomal cluster containing gene pncB. A similar chromosomal arrangement can be 
found for the canonical nadE gene in a number of Gram-positive bacteria, as illustrated 
here for Desulfitobacterium sp Y51. Both genes, pncB and nadE from the latter 
organism, are close homologs of pncB and nadE* genes from Pasteurellaceae (~43% 
and 48% identity, respectively).  Genes surrounding this cluster and not conserved 




A. succinogenes pncB nadE*
M. succiniciproducens pncB nadE*
Desulfitobacterium sp Y51 pncB nadE
HGT 2 endows an ancestor of all Francisella spp with a Route II of NAD synthesis (nadE*-
nadM), which could lead to the consecutive loss of a redundant Route I (nadD-nadE).  
HGT 1 followed by evolution of the NMN synthetase specificity provides these 
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